UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D. C. 20549

 


 

FORM 10-Q

 


 

Quarterly report pursuant to Section 13 or15(d) of the Securities and Exchange Act of 1934

 

For the quarterly period ended March 31, 2024

 

Transition report pursuant to Section 13 or 15(d) of the Exchange Act

 

For the transition period from                                   to                                 .

 

Commission File Number: 0-9376

innovfood20240331_10qimg001.jpg

 

INNOVATIVE FOOD HOLDINGS, INC.

(Exact Name of Registrant as Specified in its Charter)

 

Florida

(State or Other Jurisdiction of Incorporation or Organization)

20-1167761

(IRS Employer I.D. No.)

 

9696 Bonita Beach Rd., Ste. 208, Bonita Springs, Florida 34135

(Address of Principal Executive Offices)

 

(239) 596-0204

(Registrant’s Telephone Number, Including Area Code)

 

                                                                                                                          

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act: None.

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

N/A

 

N/A

 

N/A

 

 

 

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

(Check One):

Large Accelerated filer ☐

Accelerated filer ☐

Non-accelerated filer ☒

Smaller reporting company

Emerging growth company

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Regulation 12b-2 of the Exchange Act): Yes ☐ No

 

State the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 49,693,803 shares of common stock outstanding as of May 13, 2024.

 

 

 

 

INNOVATIVE FOOD HOLDINGS, INC.

TABLE OF CONTENTS TO FORM 10-Q

 

 

 

Page

PART I.

FINANCIAL INFORMATION

 

 

 

 

Item 1.

Consolidated Financial Statements (unaudited)

4

 

Consolidated Balance Sheets

4

 

Consolidated Statements of Operations

5

 

Consolidated Statement of Stockholders’ Equity

6

 

Consolidated Statements of Cash Flows

7

 

Condensed Notes to the Consolidated Financial Statements

8

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations (including cautionary statement)

26

Item 4.

Controls and Procedures

32

 

 

 

PART II.

OTHER INFORMATION

 

 

 

 

Item 1.

Legal Proceedings

33

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

33

Item 3.

Defaults Upon Senior Securities

33

Item 4.

Mine Safety Disclosures

33

Item 5.

Other Information

33

Item 6.

Exhibits

34

 

Signatures

35

 

 

 

PART I. FINANCIAL INFORMATION

 

ITEM 1 - CONSOLIDATED FINANCIAL STATEMENTS

 

Innovative Food Holdings, Inc.

Consolidated Balance Sheets

 

   

March 31,

   

December 31,

 
   

2024

   

2023

 
   

(unaudited)

         

ASSETS

               

Current assets

               

Cash and cash equivalents

  $ 4,272,243     $ 5,327,016  

Accounts receivable, net

    4,109,274       4,307,726  

Inventory, net

    2,840,682       2,973,134  

Other current assets

    348,926       287,528  

Assets held for sale

    5,941,933       649,884  

Current assets - discontinued operations

    20,649       95,861  

Total current assets

    17,533,707       13,641,149  
                 

Property and equipment, net

    974,143       7,000,015  

Right of use assets, operating leases, net

    24,344       28,519  

Right of use assets, finance leases, net

    411,488       436,403  

Tradenames and other unamortizable intangible assets

    217,000       217,000  

Total assets

  $ 19,160,682     $ 21,323,086  
                 

LIABILITIES AND STOCKHOLDERS' EQUITY

               

Current liabilities

               

Accounts payable and accrued liabilities

  $ 3,111,671       6,252,951  

Accrued separation costs, related parties, current portion

    418,635       463,911  

Accrued interest

    93,829       95,942  

Deferred revenue

    1,227,936       1,312,837  

Stock appreciation rights liability

    373,918       255,020  

Notes payable - current portion

    100,237       121,041  

Lease liability - operating leases, current

    17,422       17,131  

Lease liability - finance leases, current

    136,096       115,738  

Current liabilities - discontinued operations

    2,522       6,422  

Total current liabilities

    5,482,266       8,640,993  
                 

Note payable, net of discount

    8,501,474       8,855,000  

Accrued separation costs, related parties, non-current

    707,692       791,025  

Lease liability - operating leases, non-current

    6,922       11,388  

Lease liability - finance leases, non-current

    148,931       219,266  

Total liabilities

    14,847,285       18,517,672  
                 

Commitments & Contingencies (see note 18)

               

Stockholders' equity

               

Common stock: $0.0001 par value; 500,000,000 shares authorized; 52,516,974 and 52,538,100 shares issued, and 49,693,803 and 49,714,929 shares outstanding at March 31, 2024 and December 31, 2023, respectively

    5,249       5,251  

Additional paid-in capital

    42,844,922       42,762,811  

Treasury stock: 2,623,171 shares outstanding at March 31, 2024 and December 31, 2023

    (1,141,370 )     (1,141,370 )

Accumulated deficit

    (37,395,404 )     (38,821,278 )

Total stockholders' equity

    4,313,397       2,805,414  
                 

Total liabilities and stockholders' equity

  $ 19,160,682     $ 21,323,086  

 

See condensed notes to these unaudited consolidated financial statements.

 

4

 

Innovative Food Holdings, Inc.

Consolidated Statements of Operations

(unaudited)

 

   

For the Three

   

For the Three

 
   

Months Ended

   

Months Ended

 
   

March 31,

   

March 31,

 
   

2024

   

2023

 
   

(unaudited)

   

(unaudited)

 
                 

Revenue

    15,730,113       16,674,759  

Cost of goods sold

    11,895,799       12,900,609  

Gross margin

    3,834,314       3,774,150  
                 

Selling, general and administrative expenses

    4,013,427       4,444,394  

Separation costs - executive officers

    -       1,945,650  

Total operating expenses

    4,013,427       6,390,044  
                 

Operating (loss)

    (179,113 )     (2,615,894 )
                 

Other income (expense):

               

Interest expense, net

    (215,450 )     (172,721 )

Gain on sale of assets

    1,807,516       -  

Gain on sale of subsidiary

    21,126       -  

Other leasing income

    1,900       1,900  

Total other income (expense)

    1,615,092       (170,821 )
                 

Net income (loss) before taxes

    1,435,979       (2,786,715 )
                 

Income tax expense

    -       -  
                 

Net income (loss) from continuing operations

  $ 1,435,979     $ (2,786,715 )
                 

Net (loss) from discontinued operations

  $ (10,105 )   $ (42,051 )
                 

Consolidated net income (loss)

  $ 1,425,874     $ (2,828,766 )
                 

Net income (loss) per share from continuing operations - basic

  $ 0.029     $ (0.06 )
                 

Net income (loss) per share from continuing operations - diluted

  $ 0.028     $ (0.06 )
                 

Net income (loss) per share from discontinued operations - basic

  $ (0.00 )   $ (0.00 )
                 

Net income (loss) per share from discontinued operations - diluted

  $ (0.00 )   $ (0.00 )
                 

Weighted average shares outstanding - basic

    49,707,036       48,462,234  
                 

Weighted average shares outstanding - diluted

    50,603,891       48,462,234  

 

See condensed notes to these unaudited consolidated financial statements.

 

5

 

Innovative Food Holdings, Inc.

Consolidated Statements of Stockholders' Equity

Three Months Ended March 31, 2024 and 2023

(unaudited)

 

   

Common Stock

   

Common Stock

to be issued

   

Additional Paid-in

   

Treasury Stock

   

Accumulated

         
   

Amount

   

Value

   

Amount

   

Value

   

Capital

   

Amount

   

Value

   

Deficit

   

Total

 
                                                                         

Balance - December 31, 2022

    49,427,297     $ 4,938       1,499,940     $ 150     $ 42,189,471       2,623,171     $ (1,141,370 )   $ (34,466,126 )   $ 6,587,063  

Shares issued for compensation

    -       -       207,274       20       45,660       -       -       -       45,680  

Shares issued to management and employees, previously accrued

    875,000       87       (875,000 )     (87 )     -       -       -       -       -  

Fair value of shares under compensation plan

    -       -       -       -       20,199       -       -       -       20,199  

Common stock issued for services

    267,030       27       -       -       112,142       -       -       -       112,142  

Net loss for the three months ended March 31, 2023

    -       -       -       -       -       -       -       (2,828,766 )     (2,828,766 )

Balance - March 31, 2023

    50,569,327     $ 5,052       832,214     $ 83     $ 42,367,472       2,623,171     $ (1,141,370 )   $ (37,294,892 )   $ 3,936,345  
                                                                         

Balance - December 31, 2023

    52,538,100     $ 5,251       -       -     $ 42,762,811       2,623,171     $ (1,141,370 )   $ (38,821,278 )   $ 2,805,414  

Shares returned to treasury from sale of subsidiary

    (21,126 )     (2 )     -       -       (21,124 )     -       -       -       (21,126 )

Fair value of shares under compensation plan

    -       -       -       -       103,235       -       -       -       103,235  

Net income for the three months ended March 31, 2024

    -       -       -       -       -       -       -       1,425,874       1,425,874  

Balance - March 31, 2024

    52,516,974     $ 5,249       -     $ -     $ 42,844,922       2,623,171     $ (1,141,370 )   $ (37,395,404 )   $ 4,313,397  

 

See condensed notes to these unaudited consolidated financial statements.

 

6

 

Innovative Food Holdings, Inc.

Consolidated Statements of Cash Flows

 

   

For the Three

   

For the Three

 
   

Months Ended

   

Months Ended

 
   

March 31,

   

March 31,

 
   

2024

   

2023

 
   

(unaudited)

   

(unaudited)

 

Cash flows from operating activities:

               

Net income (loss)

  $ 1,425,874     $ (2,828,766 )

Adjustments to reconcile net income (loss) to net cash used in operating activities:

               

Gain on disposition of asset

    (1,807,516 )     -  

Gain on sale of subsidiary

    (21,126 )     -  

Depreciation and amortization

    110,260       145,387  

Amortization of right of use asset

    4,175       16,314  

Amortization of discount on notes payable

    1,283       -  

Stock based compensation

    103,235       178,048  

Loss on value of stock appreciation rights

    118,898       -  

Provision for doubtful accounts

    22,882       4,666  
                 

Changes in assets and liabilities:

               

Accounts receivable, net

    175,436       135,020  

Inventory and other current assets, net

    71,054       (51,038 )

Accounts payable and accrued liabilities

    (3,144,335 )     (2,056,459 )

Accrued separation costs - related parties

    (128,610 )     1,600,795  

Deferred revenue

    (84,548 )     (319,365 )

Operating lease liability

    (4,175 )     (16,314 )

Net cash used in operating activities

    (3,157,213 )     (3,191,712 )
                 

Cash flows from investing activities:

               

Acquisition of property and equipment

    (1,406 )     (7,995 )

Cash received from disposition of asset, net of loan payoff

    2,101,185       -  

Net cash from (used in) investing activities

    2,099,779       (7,995 )
                 

Cash flows from financing activities:

               

Principal payments on debt

    (22,708 )     (2,757 )

Principal payments financing leases

    (49,977 )     (46,807 )

Net cash (used in) financing activities

    (72,685 )     (49,564 )
                 

Decrease in cash and cash equivalents

    (1,130,119 )     (3,249,271 )
                 

Cash and cash equivalents at beginning of period

    5,422,335       4,899,398  
                 

Cash and cash equivalents at end of period - continuing operations

  $ 4,272,243     $ 1,435,561  

Cash and cash equivalents at end of period - discontinued operations

  $ 19,973     $ 214,566  

Cash and cash equivalents at end of period

  $ 4,292,216     $ 1,650,127  
                 

Supplemental disclosure of cash flow information:

               
                 

Cash paid during the period for:

               

Interest

  $ 228,970     $ 174,410  
                 

Taxes

  $ -     $ -  
                 

Non-cash investing and financing activities:

               

Reclassify fixed assets as held for sale

  $ 5,941,933     $ -  

Principal and accrued interest paid from escrow to Maple Mark Bank

  $ 353,815     $ -  

 

See condensed notes to these unaudited consolidated financial statements.

 

7

 

INNOVATIVE FOOD HOLDINGS, INC.

CONDENSED NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2024

(Unaudited)

 

1. NATURE OF ACTIVITIES AND SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying unaudited interim consolidated financial statements include those of Innovative Food Holdings, Inc. and all of its wholly-owned subsidiaries (collectively, the “Company”) and have been prepared in accordance with generally accepted accounting principles pursuant to Regulation S-X of the Securities and Exchange Commission and with the instructions to Form 10-Q. Certain information and footnote disclosures normally included in audited consolidated financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted. Accordingly, these interim financial statements should be read in conjunction with the Company’s audited financial statements and related notes as contained in Form 10-K for the year ended December 31, 2023. In the opinion of management, the interim unaudited consolidated financial statements reflect all adjustments, including normal recurring adjustments, necessary for fair presentation of the interim periods presented. The results of the operations for the three months ended March 31, 2024 are not necessarily indicative of the results of operations to be expected for the full year.

 

Business Activity

 

We provide difficult-to-find specialty foods primarily to both Professional Chefs and Home Gourmets through our relationships with producers, growers, makers and distributors of these products worldwide. The distribution of these products primarily originates from our three unified warehouses and those of our drop ship partners, and is driven by our proprietary technology platform. In addition, we provide value-added services through our team of food specialists and Chef Advisors who offer customer support, menu ideas, and preparation guidance.

 

Restructuring

 

During the fourth quarter of 2023 we made the decision to focus more on our Business to Business (B2B) activities and less on our Direct to Consumer (D2C) products. Our subsidiaries GROW and Oasis were sold effective December 29, 2023; Haley was sold effective February 26, 2024; and the activities of P Innovations will be abandoned. Our remaining D2C business, primarily operated within igourmet and Mouth, will be downsized. See note 2.

 

Discontinued Operations

 

Pursuant to the guidance of ASC 205-20 Presentation of Financial Statements Discontinued Operations, the accounts of our discontinued entities GROW, Oasis, Haley, and P Innovations have been included in “Net loss from discontinued operations” in our consolidated statements of operations until such time as each entity was sold. Additionally, the assets and liabilities of these entities have been presented as discontinued operations in our consolidated balance sheets as of March 31, 2024 and December 31, 2023 until such time as each entity was sold. See Note 2.

 

Reclassifications

 

Certain amounts presented in the financial statements of the prior period have been reclassified to conform with the current period presentation of discontinued operations. See note 2.

 

Use of Estimates

 

The preparation of these unaudited consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate these estimates, including those related to revenue recognition and concentration of credit risk. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Accounts subject to estimate and judgements are accounts receivable reserves, inventory reserves, income taxes, intangible assets, operating and finance right of use assets and liabilities, and equity-based instruments. Actual results may differ from these estimates under different assumptions or conditions. We believe our estimates have not been materially inaccurate in past years, and our assumptions are not likely to change in the foreseeable future.

 

8

 

Concentrations of Credit Risk

 

Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash, cash equivalents and trade receivables. The Company places its cash and temporary cash in investments with credit quality institutions. At times, such investments may be in excess of applicable government mandated insurance limit. At March 31, 2024 and 2023, trade receivables from the Company’s largest customer amounted to 32% and 23%, respectively, of total trade receivables. During the three months ended March 31, 2024 and 2023, sales from the Company’s largest customer amounted to 49% and 47% of total sales, respectively.

 

The Company maintains cash balances in excess of Federal Deposit Insurance Corporation limits. At March 31, 2024 and December 31, 2023, the total cash in excess of these limits was $931,857 and $988,825, respectively.

 

Accounts Receivable

 

The Company provides an allowance for doubtful accounts equal to the estimated uncollectible amounts pursuant to the guidance of Accounting Standards Update (ASU) 2016-13, Financial Instruments – Credit Losses (Topic 326) as codified in Accounts Standards Codification (ASC) 326, Financial Instruments – Credit Losses. Under ASC 326, the Company utilizes a current and expected credit loss (CECL) impairment model. ASU 2016-13 became effective for us on January 1, 2023. The Company’s estimate is based on historical collection experience and a review of the current status of trade accounts receivable. It is reasonably possible that the Company’s estimate of the allowance for doubtful accounts will change. Accounts receivable are presented net of an allowance for doubtful accounts of $69,359 and $46,477 at March 31, 2024 and December 31, 2023, respectively.

 

Leases

 

The Company accounts for leases in accordance with Financial Accounting Standards Board (“FASB”) ASC 842, “Leases”. The Company determines if an arrangement is a lease at inception. Operating lease right-of-use assets (“ROU assets”) and short-term and long-term lease liabilities are included on the face of the consolidated balance sheet. Finance lease ROU assets are presented within other assets, and finance lease liabilities are presented within current and long-term liabilities.

 

ROU assets represent the right of use to an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The operating lease ROU asset also excludes lease incentives. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. The Company has lease agreements with lease and non-lease components, which are accounted for as a single lease component. For lease agreements with terms less than 12 months, the Company has elected the short-term lease measurement and recognition exemption, and it recognizes such lease payments on a straight-line basis over the lease term.

 

Revenue Recognition

 

The Company recognizes revenue upon product delivery. All of our products are shipped either same day or overnight or through longer shipping terms to the customer and the customer takes title to product and assumes risk and ownership of the product when it is delivered. Shipping charges to customers and sales taxes collectible from customers, if any, are included in revenues.

 

For revenue from product sales (i.e., specialty foodservice and e-commerce), the Company recognizes revenue in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 606 Revenue from Contracts with Customers”. A five-step analysis must be met as outlined in Topic 606: (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations, and (v) recognize revenue when (or as) performance obligations are satisfied. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. The Company defers any revenue for which the product has not been delivered or is subject to refund until such time that the Company and the customer jointly determine that the product has been delivered or no refund will be required.

 

Warehouse and logistic services revenue is primarily comprised of inventory management, order fulfilment and warehousing services. Warehouse & logistics services revenues are recognized at the point in time when the services are rendered to the customer.

 

9

 

Deferred Revenue

 

Certain customer arrangements in the Company’s business such as gift cards and e-commerce subscription purchases result in deferred revenues when cash payments are received in advance of performance. Gift cards issued by the Company generally have an expiration of five years from date of purchase. The Company records a liability for unredeemed gift cards and advance payments for monthly club memberships as cash is received, and the liability is reduced when the card is redeemed or product delivered.

 

The following table represents the changes in deferred revenue as reported on the Company’s consolidated balance sheets:

 

Balance as of December 31, 2022

  $ 1,558,155  

Cash payments received

    215,346  

Net sales recognized

    (534,711 )

Balance as of March 31, 2023 (unaudited)

  $ 1,238,790  

 

Balance as of December 31, 2023

  $ 1,312,837  

Cash payments received

    4,033,077  

Net sales recognized

    (4,117,978 )

Balance as of March 31, 2024 (unaudited)

  $ 1,227,936  

 

Disaggregation of Revenue

 

The following table represents a disaggregation of revenue for the three months ended March 31, 2024 and 2023:

 

   

Three Months Ended

 
   

March 31,

 
   

2024

   

2023

 
   

(unaudited)

   

(unaudited)

 

Specialty Foodservice

  $ 13,993,565     $ 13,804,785  

E-Commerce

    1,528,337       2,621,405  

Logistics

    208,211       248,569  

Total

  $ 15,730,113     $ 16,674,759  

 

Cost of goods sold

 

We have included in cost of goods sold all costs which are directly related to the generation of revenue. These costs include primarily the cost of food and raw materials, packing and handling, shipping, and delivery costs.

 

We have also included all payroll costs as cost of goods sold in our leasing and logistics services business.

 

Basic and Diluted Earnings Per Share

 

Basic net earnings per share is based on the weighted average number of shares outstanding during the period, while fully-diluted net earnings per share is based on the weighted average number of shares of common stock and potentially dilutive securities assumed to be outstanding during the period using the treasury stock method. Potentially dilutive securities consist of options and warrants to purchase common stock, and convertible debt. Basic and diluted net loss per share is computed based on the weighted average number of shares of common stock outstanding during the period.

 

The Company uses the treasury stock method to calculate the impact of outstanding stock options and warrants. Stock options and warrants for which the exercise price exceeds the average market price over the period have an anti-dilutive effect on earnings per common share and, accordingly, are excluded from the calculation.

 

10

 

Dilutive shares at March 31, 2024:

 

Stock Options

 

The following table summarizes the options outstanding and the related prices for the options to purchase shares of the Company’s common stock issued by the Company at March 31, 2024:

 

               

Weighted

 
               

average

 
               

Remaining

 

Exercise

   

Number of

   

contractual

 

Price

   

Options

   

life (years)

 
$ 0.41       125,000       0.07  
$ 0.50       125,000       0.07  
$ 0.60       50,000       1.75  
$ 1.00       50,000       1.75  
$ 1.25       130,000       2.25  
$ 1.75       130,000       2.25  
          610,000       1.27  

 

Restricted Stock Awards

 

At March 31, 2024, there are 300,000 unvested restricted stock awards remaining from grants in a prior year. Those 300,000 restricted stock awards will vest as follows: 125,000 restricted stock awards will vest contingent upon the attainment of a stock price of $2.00 per share for 20 straight trading days, and an additional 175,000 restricted stock awards will vest contingent upon the attainment of a stock price of $3.00 per share for 20 straight trading days. The fair value of these RSUs at the date of the grants will be charged to operations upon vesting. At March 31, 2024, none of these RSU were vested. There was no charge to operations for these RSUs during the three months ended March 31, 2024.

 

Stock-based Compensation

 

At March 31, 2024, there were a total of 3,910,534 shares of common stock potentially issuable to the Company’s executive officers pursuant to compensation plans and contingent upon the achievement of certain performance goals; see notes 15 and 16.

 

Dilutive shares at March 31, 2023:

 

Stock Options

 

The following table summarizes the options outstanding and the related prices for the options to purchase shares of the Company’s common stock issued by the Company at March 31, 2023:

 

               

Weighted

 
               

Average

 
               

Remaining

 

Exercise

   

Number

   

Contractual

 

Price

   

of Options

   

Life (years)

 
$ 0.41       125,000       1.07  
$ 0.50       125,000       1.07  
$ 0.60       50,000       2.75  
$ 0.62       360,000       0.75  
$ 0.85       540,000       0.75  
$ 1.00       50,000       2.75  
$ 1.20       950,000       0.74  
          2,200,000       0.87  

 

11

 

Restricted Stock Awards

 

At March 31, 2023, there are 300,000 unvested restricted stock awards remaining from grants in a prior year. Those 300,000 restricted stock awards will vest as follows: 125,000 restricted stock awards will vest contingent upon the attainment of a stock price of $2.00 per share for 20 straight trading days, and an additional 175,000 restricted stock awards will vest contingent upon the attainment of a stock price of $3.00 per share for 20 straight trading days. At March 31, 2023, none of these RSU were vested. There was no charge to operations for these RSUs during the three months ended March 31, 2023.

 

Stock-based Compensation

 

At March 31, 2023, there were a total of 3,538,243 shares of common stock potentially issuable to the Company’s Chief Executive Officer pursuant to his compensation plan and contingent upon the achievement of certain performance goals. see notes 15 and 16.

 

New Accounting Pronouncements

 

Management does not believe that any other recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on the accompanying consolidated financial statements.

 

2. DISCONTINUED OPERATIONS

 

During the fourth quarter of fiscal 2023, in connection with an analysis of the Company’s sales mix and profitability by service offering, management made the strategic decision to focus on the Company’s Business to Business (B2B) service offering and to allocate fewer resources to and in some cases to sell certain of the Company’s subsidiaries involved in our Direct to Consumer (D2C) service offerings. Pursuant to this strategy, on December 29, 2023, the Company completed the sales of its Grow and Oasis subsidiaries, and on February 26, 2024, the Company completed the sale of its Haley subsidiary (see note 3). In addition, the operations of P Innovations has been abandoned.

 

The following information presents the major classes of line item of assets and liabilities included as part of discontinued operations in the consolidated balance sheets:

 

   

March 31,

   

December 31,

 
   

2024

   

2023

 

Current assets - discontinued operations:

 

(unaudited)

         

Cash

  $ 19,973     $ 95,319  

Accounts receivable

    635       501  

Inventory

    41       41  

Other current assets

    -       -  

Total current assets - discontinued operations

  $ 20,649     $ 95,861  
                 

Current liabilities - discontinued operations:

               

Accounts payable and accrued liabilities

  $ -     $ 986  

Accrued payroll and related liabilities

    -       3,267  

Deferred revenue

    2,522       2,169  

Total current liabilities - discontinued operations

  $ 2,522     $ 6,422  

 

The following information presents the major classes of line items constituting the after-tax loss from discontinued operations in the consolidated statements of operations:

 

   

Three Months Ended

 
   

March 31,

   

March 31,

 
   

2024

   

2023

 

Revenue

  $ 24,856     $ 320,441  

Cost of goods sold

    (2,238 )     (8,080 )

Gross margin

    22,618       312,361  
                 

Selling, general, and administrative expenses

    (32,723 )     (354,692 )
                 

Interest income

    -       280  

Loss from discontinued operations, net of tax

  $ (10,105 )   $ (42,051 )

 

12

 

There were no major classes of line items which constituted significant operating and investing cash flow activities in the consolidated statements of cash flows relating to discontinued operations.

 

3. SALE OF SUBSIDIARY

 

On February 26, 2024, the Company sold 100% of the equity interests in Haley Food Group, Inc., (“Haley”) for the return of 21,126 shares of the Company’s common stock held by the buyer. The Company Haley had no assets of liabilities at the time of the sale; the Company valued the 21,126 shares of common stock at the market price on the date of the acquisition of $1.00 per sale and recorded a gain in the amount of $21,126 on this transaction.

 

4. ACCOUNTS RECEIVABLE

 

At March 31, 2024 and December 31, 2023, accounts receivable consists of:

 

   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

Accounts receivable from customers

  $ 4,178,633     $ 4,354,203  
Allowance for doubtful accounts     (69,359 )     (46,477 )

Accounts receivable, net

  $ 4,109,274     $ 4,307,726  

 

During the three months ended March 31, 2024 and 2023, the Company charged the amount of $22,882 and $4,666 to provision for credit loss, respectively.

 

5. INVENTORY

 

Inventory consists primarily of specialty food products. At March 31, 2024 and December 31, 2023, inventory consisted of the following:

 

   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

Finished goods inventory

  $ 2,840,682     $ 2,973,134  

Allowance for slow moving & obsolete inventory

    -       -  

Finished goods inventory, net

  $ 2,840,682     $ 2,973,134  

 

6. PROPERTY AND EQUIPMENT

 

A summary of property and equipment at March 31, 2024 and December 31, 2023 is as follows:

 

   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

Land

  $ 208,140     $ 1,079,512  

Building

    711,409       6,571,496  

Computer and Office Equipment

    599,242       597,834  

Warehouse Equipment

    477,090       477,090  

Furniture and Fixtures

    940,960       940,960  

Vehicles

    58,353       58,353  

Total before accumulated depreciation

    2,995,194       9,725,245  

Less: accumulated depreciation

    (2,021,051 )     (2,725,230 )

Total

  $ 974,143     $ 7,000,015  

 

Depreciation expense for property and equipment amounted to $85,345 and $101,576 for the three months ended March 31, 2024 and 2023, respectively. Depreciation expense for property and equipment is recorded in selling, general & administrating expenses on the Company’s statement of operations. During the three months ended March 31, 2024 and 2023, the Company acquired property and equipment in the amount of $1,406 and $7,995, respectively.

 

13

 

7. PROPERTY AND EQUIPMENT CLASSIFIED AS HELD FOR SALE

 

Assets held for sale include the net book value of property and equipment the Company plans to sell within the next year. Long lived assets that meet the criteria are held for sale and reported at the lower of their carrying value or fair value less estimated cost to sell.

 

As of December 31, 2023, the Company classified the land, building, leasehold improvements, and certain equipment located at 28411 Race Track Road, Bonita Springs, Florida, 34135 (the “Race Track Road Property”) as held for sale. On February 14, 2024, the Company finalized the sale of the Race Track Road Property for cash in the amount of $2,455,000. The Company recorded a gain on the sale in the amount of $1,807,516. Proceeds of the sale in the amount of $353,815 were used to pay the mortgage and accrued interest on the Race Track Road Property. Total expenses related to the sale $165,755, including a commission of $147,300, state taxes of $17,185, and closing fees of $1,270.

 

As of March 31, 2024, the Company classified the land and building located at 220 Oak Hill Road, Mountain Top, Pennsylvania, as held for sale.

 

The net book value of these assets consisted of the following at March 31, 2024 and December 31, 2023:

 

   

March 31,

   

December 31,

 
   

2024

   

2023

 
                 

Land

  $ 871,372     $ 177,383  

Building

    5,070,561       431,147  

Furniture, fixtures, and equipment

    -       41,314  

Total

  $ 5,941,933     $ 649,844  

 

8. RIGHT OF USE (ROU) ASSETS AND LEASE LIABILITIES OPERATING LEASES

 

The Company has operating leases for offices, warehouses, vehicles, and office equipment. The Company’s leases have remaining lease terms of 1 year to 3 years, some of which include options to extend.

 

The Company’s lease expense for the three months ended March 31, 2024 and 2023 was entirely comprised of operating leases and amounted to $8,165 and $18,790, respectively.

 

The Company’s ROU asset amortization for the three months ended March 31, 2024 and 2023 was $4,175 and $16,314, respectively. The difference between the lease expense and the associated ROU asset amortization consists of interest.

 

Right of use assets – operating leases are summarized below:

 

   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

Warehouse equipment

  $ 18,477     $ 21,869  

Office equipment

    5,867       6,650  

Right of use assets, net

  $ 24,344     $ 28,519  

 

Operating lease liabilities are summarized below:

 

   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

Warehouse equipment

  $ 18,477     $ 21,869  

Office equipment

    5,867       6,650  

Lease liability

  $ 24,344     $ 28,519  

Less: current portion

    (17,422 )     (17,131 )

Lease liability, non-current

  $ 6,922     $ 11,388  

 

14

 

Maturity analysis under these lease agreements are as follows:

 

For the period ended March 31, 2025

  $ 18,532  

For the period ended March 31, 2026

    7,051  

Total

  $ 25,583  

Less: Present value discount

    (1,239 )

Lease liability

  $ 24,344  

 

9. RIGHT OF USE ASSETS FINANCING LEASES

 

The Company has financing leases for vehicles and warehouse equipment. Right of use asset – financing leases are summarized below:

 

   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

Vehicles

  $ 404,858     $ 404,858  

Warehouse Equipment

    555,416       555,416  

Total before accumulated depreciation

    960,274       960,274  

Less: accumulated depreciation

    (548,786 )     (523,871 )

Total

  $ 411,488     $ 436,403  

 

Depreciation expense related to right of use assets for the three months ended March 31, 2024 and 2023 was $24,915 and $33,480, respectively.

 

Financing lease liabilities are summarized below:

 

   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

Financing lease obligation under a lease agreement for a forklift dated July 12, 2021 in the original amount of $16,070 payable in thirty-six monthly installments of $489 including interest at the rate of 6.01%. During the three months ended March 31, 2024, the Company made principal and interest payments on this lease obligation in the amounts of $1,431 and $36, respectively.

  $ 1,453     $ 2,884  
                 

Financing lease obligation under a lease agreement for a pallet truck dated July 15, 2021 in the original amount of $5,816 payable in thirty-six monthly installments of $177 including interest at the rate of 6.01%. During the three months ended March 31, 2024, the Company made principal and interest payments on this lease obligation in the amounts of $518 and $13, respectively.

  $ 526     $ 1,044  
                 

Financing lease obligation under a lease agreement for warehouse furniture and equipment truck dated October 14, 2020 in the original amount of $514,173 payable in sixty monthly installments of $9,942 including interest at the rate of 6.01%. During the three months ended March 31, 2024, the Company made principal and interest payments on this lease obligation in the amount of $19,084 and $2,834, respectively.

  $ 170,712     $ 197,707  

 

15

 

   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

Financing lease obligation under a lease agreement for a truck dated March 31, 2020 in the original amount of $152,548 payable in eighty-four monthly installments of $2,188 including interest at the rate of 5.44%. During the three months ended March 31, 2024, the Company made principal and interest payments on this lease obligation in the amounts of $5,552 and $1,012, respectively.

  $ 70,666     $ 76,218  
                 

Financing lease obligation under a lease agreement for a truck dated November 5, 2018 in the original amount of $128,587 payable in seventy monthly installments of $2,326 including interest at the rate of 8.33%. During the three months ended March 31, 2024, the Company made principal and interest payments on this lease obligation in the amounts of $6,647 and $330, respectively.

    11,388     $ 18,035  
                 

Financing lease obligation under a lease agreement for a truck dated August 23, 2019 in the original amount of $80,413 payable in eighty-four monthly installments of $1,148 including interest at the rate of 5.0%. During the three months ended March 31, 2024, the Company made principal and interest payments on this lease obligation in the amounts of $3,040 and $404, respectively.

  $ 30,282     $ 33,322  
                 

Financing lease obligation under a lease agreement for a truck dated February 4, 2022 in the original amount of $42,500 payable in twenty-four monthly installments of $1,963 including interest at the rate of 10.1%. During the three months ended March 31, 2024, the Company made principal and interest payments on this lease obligation in the amounts of $5,794 and $98, respectively.

  $ -     $ 5,794  
                 

Total

  $ 285,027     $ 335,004  
                 

Current portion

  $ 136,096     $ 115,738  

Long-term maturities

    148,931       219,266  

Total

  $ 285,027     $ 335,004  

 

There was no accrued interest on financing leases at March 31, 2024 and December 31, 2023.

 

Aggregate maturities of lease liabilities:

 

For the twelve months ended March 31,

 

2025

  $ 160,993  

2026

    96,060  

2027

    27,974  

Total

  $ 285,027  

 

10. INTANGIBLE ASSETS

 

The Company acquired certain intangible assets pursuant to the acquisitions of Artisan, Oasis, igourmet, OFB, Haley, and Mouth. These assets include non-compete agreements, customer relationships, trade names, internally developed technology, and goodwill. The Company has also capitalized the development of its website.

 

Other Non-Amortizable Intangible Assets

 

Other non-amortizable intangible assets consist of $217,000 of trade names held by Artisan. The Company followed the guidance of ASC 360 “Property, Plant, and Equipment” (“ASC 360”) in assessing these assets for impairment. ASC 360 states that impairment testing should be completed whenever events or changes in circumstances indicate the asset’s carrying value may not be recoverable. In management’s judgment there are no indications that the carrying value of these trade names may not be recoverable, and it determined that impairment testing was not required.

 

16

 

The Company acquired certain intangible assets pursuant to the acquisitions through Artisan. The following is the net book value of these assets:

 

   

March 31, 2024

(unaudited)

 
           

Accumulated

         
   

Gross

   

Amortization

   

Net

 

Trade Names

  $ 217,000     $ -     $ 217,000  

 

   

December 31, 2023

 
           

Accumulated

         
   

Cost

   

Amortization

   

Net

 

Total Trade Names

  $ 217,000     $ -     $ 217,000  

 

Total amortization expense for the three months ended March 31, 2024 and 2023 was $0.

 

11. ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

 

Accounts payable and accrued liabilities at March 31, 2024 and December 31, 2023 are as follows:

 

   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

Trade payables and accrued liabilities

  $ 2,955,157     $ 6,046,396  

Accrued payroll and commissions

    156,514       206,555  

Total

  $ 3,111,671     $ 6,252,951  

 

12. ACCRUED SEPARATION COSTS RELATED PARTIES

 

On February 3, 2023, the Company entered into a Severance Note, an Agreement and General Release, and a Side Letter thereto with Sam Klepfish (the “SK Agreements”), its prior CEO and a current board member. The SK Agreements provide, among other things, for Mr. Kelpfish’s resignation from all positions with the Company and its subsidiaries on February 28, 2023, except that Mr. Klepfish will remain a director and member of the board of the Company, confidentiality and non-disparagement conditions, nomination of Mr. Klepfish for future election to the board of directors at least through the 2024 general meeting of shareholders based on certain minimum stock ownership and Board Observer rights when Mr. Klepfish is no longer a director but maintains certain minimum agreed upon stock ownership. The payment terms are $250,000 upon effectiveness and an additional $1,000,000 payable in weekly payments of $6,410.26 from March 8, 2023 through March 6, 2026. The $250,000 was paid into an escrow account with the requirement that they are released to Mr. Klepfish on his separation date. The $1,000,000 portion is in the form of an unsecured, non-interest bearing note payable to Mr. Klepfish. The SK Agreements also call for the delivery of 400,000 shares of the Company’s common stock valued at $168,000 based upon the closing price of the Company’s common stock on Mr. Klepfish’s separation date of February 28, 2023; in addition, for delivery on June 1, 2027 of additional shares of the Company’s common stock equal to the greater of (i) the number of shares with an aggregate fair market value of $400,000 on such date, or (ii) 266,666 shares. The Company also agreed to pay a total of $1,199 of Cobra insurance costs on behalf of Mr. Klepfish over eighteen months. The total amount accrued in connection with the SK Agreements was $1,819,199.

 

On February 28, 2023, the Company entered into a separation agreement (the “Wiernasz Separation Agreement”) with Justin Wiernasz, a director and previous Director of Strategic Acquisitions. Pursuant to the Wiernasz Separation Agreement, the Company agreed to a payment of $100,000 in cash as follows: $33,333 upon execution of the agreement, $33,333 on March 15, 2023, and $33,334 on April 15, 2023. The Company also agreed to make the Cobra insurance payments on behalf of Mr. Wiernasz in the amount of $2,548 per month for twelve months with a maximum of $26,451. The total amount accrued in connection with the Wiernasz Separation Agreement was $126,451.

 

17

 

On February 6, 2024, the Company entered into a separation agreement with Richard Tang, its Chief Financial Officer (the “Tang Separation Agreement”) effective as of December 31, 2023. Pursuant to the Tang Separation Agreement, the Company will pay to Mr. Tang, in equal installments over a five month period, the gross sum of $113,918. In addition, Mr. Tang may submit for reimbursement up to $4,000 of legal expenses connected with the review of this separation agreement. The severance payment will be made in the following installments: (i) $25,890 to be paid the week of March 4, 2024; (ii) $5,178 to be paid each successive week for seventeen weeks beginning the week of March 11, 2024, until the Severance Payment is completed. In addition, if Tang timely elects to continue his group health insurance benefits under the Consolidated Omnibus Reconciliation Act (“COBRA”), the Company will reimburse Tang’s group health insurance premiums (“COBRA Premiums”) for the lesser of: (a) the period of time Employee is eligible to continue his group health insurance benefits under COBRA and (b) the five-month period immediately following the Separation Date. Reimbursements will be paid within thirty days of when Tang submits a request for reimbursement and supporting documentation.

 

During the three months ended March 31, 2024, the Company paid cash in the amount of $83,333 to Mr. Klepfish in connection with the SK Agreements.

 

During the three months ended March 31, 2024, the Company made the following payments in connection with the Wiernasz Separation Agreement: The Company made Cobra payments on behalf of Mr. Weirnasz in the amount of $967.

 

During the three months ended March 31, 2024, the Company made the following payments in connection with the Tang Separation agreement: The Company paid cash to Mr. Tang in the amount of $41,125, and made Cobra payments on behalf of Mr. Tang in the amount of $2,885.

 

The following table represents the amounts accrued, paid, and outstanding on these agreements as of March 31, 2024:

 

   

Total

   

Paid / Issued

   

Balance

   

Current

   

Non-current

 

Mr. Klepfish:

                                       

Cash – through March 6, 2026

  $ 1,000,000     $ (358,975 )   $ 641,025     $ 333,333     $ 307,692  

Cash - upon agreement execution

    250,000       (250,000 )     -       -       -  

Stock - June 1, 2027

    400,000       -       400,000       -       400,000  

Stock - Issued in April 2023

    168,000       (168,000 )     -       -       -  

Cobra - over eighteen months

    1,199       -       1,199       1,199       -  

Total – Mr. Klepfish

  $ 1,819,199     $ (776,975 )   $ 1,042,224     $ 334,532     $ 707,692  
                                         

Mr. Wiernasz:

                                       

Cash - three equal payments

  $ 100,000     $ (100,000 )   $ -     $ -     $ -  

Cobra - over eighteen months

    26,451       (26,451 )     -       -       -  

Total - Mr. Wiernasz

  $ 126,451     $ (126,451 )   $ -     $ -     $ -  
                                         

Mr. Tang:

                                       

Cash – over seventeen weeks

  $ 113,918     $ (41,425 )   $ 72,493     $ 72,493     $ -  

Cobra - over five months

    14,495       (2,885 )     11,610       11,610       -  

Total - Mr. Tang

  $ 128,413     $ (44,310 )   $ 84,103     $ 84,103     $ -  
                                         

Total Company

  $ 2,074,063     $ (947,736 )   $ 1,126,327     $ 418,635     $ 707,692  

 

18

 

13. STOCK APPRECIATION RIGHTS LIABILITY

 

Effective May 15, 2023, the Company issued 1,500,000 stock appreciation rights (the “Smallwood SARs”) to Brady Smallwood, its Chief Operating Officer. See note 15. The Smallwood SARs were valued utilizing the Black-Scholes valuation model, and had an aggregate fair value of $9,794 upon issuance; this amount was charged to operations and credited to stock appreciation rights liability. The Smallwood SARs are revalued each quarter, and any gain or loss in the fair value is charged to non-cash compensation expense.

 

The change in valuation of the Smallwood SARs is summarized in the table below:

 

May 15, 2023 - fair value

  $ 9,794  

(Gain) Loss on revaluation

    245,226  

December 31, 2023 -fair value

  $ 255,020  

(Gain) Loss on revaluation

    118,898  

March 31, 2024 - fair value

  $ 373,918  

 

14. NOTES PAYABLE

 

   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

On June 13, 2023, the Company entered into a term loan with MapleMark Bank (the “MapleMark Term Loan 3”) in the amount of $9,057,840. Principal and interest due on the MapleMark Term Loan 1 in the amounts of $5,324,733 and $61,715, respectively, were paid with proceeds of the MapleMark Term Loan 3. The MapleMark Term Loan 3 is payable in monthly installments of $80,025 commencing July 1, 2023 and continuing through June 13, 2048.

 

Amounts outstanding under the Maple Mark Term Loan 3 will bear interest at the rate equal to the lesser of (a) the Maximum Lawful Rate, or (b) the greater of (i) WSJP (the “Prime Rate” as published by The Wall Street Journal) plus 1.25% per annum or (ii) 4.50% per annum. At March 31, 2024, the interest rate was 9.50%. The MapleMark Term Loan 3 matures on June 13, 2048.

 

The MapleMark Term Loan 3 contains negative covenants that, subject to certain exceptions, limits the ability of the Company and its subsidiaries to, among other things, incur additional indebtedness, make restricted payments, pledge their assets as security, make investments, loans, advances, guarantees and acquisitions, undergo fundamental changes and enter into transactions with affiliates. The Term Loan Agreements also provides that the Company and its subsidiaries on a consolidated basis, meet a Fixed Charge Coverage Ratio as described in detail in the Loan Agreements. The Term Loan Agreements contain events of default that are customary for a facility of this nature, including (subject in certain cases to grace periods and thresholds) nonpayment of principal, nonpayment of interest, fees or other amounts, material inaccuracy of representations and warranties, violation of covenants, cross-default to certain other existing indebtedness, bankruptcy or insolvency events, and certain judgment defaults as specified in the Term Loan Agreements. If an event of default occurs, the maturity of the amounts owed under the Term Loan Agreements may be accelerated. The obligations under the Term Loan Agreements are guaranteed by the Company and IFP and are secured by mortgages on their real estate located in Florida, Illinois, and Pennsylvania and substantially all of their assets, in each case, subject to certain exceptions and permitted liens.

 

The Company created a discount on the MapleMark Term Loan 3 for costs in the amount of $385,803 which will be amortized over the life of the loan. During the three months ended March 31, 2024, the Company amortized $1,284 of these costs to interest expense. During the three months ended March 31, 2024, the Company made principal payments and interest payments in the amount of $22,709 and $221,317, respectively, on this loan. At March 31, 2024, accrued interest on this note was $75,251.

  $ 8,962,933     $ 8,985,642  

 

19

 

   

March 31,

2024

   

December 31,

2023

 
   

(unaudited)

         

On June 6, 2022, the Company entered into a term loan agreement with MapleMark (the “MapleMark Term Loan 2”) for the original amount of $356,800. This amount was paid by MapleMark directly to Fifth Third Bank in satisfaction of the outstanding principal and interest due under existing loans with Fifth Third Bank. The MapleMark Term Loan 2 originally matured on May 27, 2023. On June 9, 2023, the USDA approved the Guarantee of MapleMark Term Loan 1 which allowed the Company to extend the term of the MapleMark Term Loan 2 from May 27, 2023 to May 27, 2033 with monthly payments in the amount of approximately $2,311 commencing July 1, 2023 and continuing through June 1, 2033. On July 1, 2033, a final payment in the amount of approximately $303,536 will be due on the MapleMark Term Loan 2.

 

The MapleMark Term Loan 2 contains negative covenants that, subject to certain exceptions, limits the ability of the Company and its subsidiaries to, among other things, incur additional indebtedness, make restricted payments, pledge their assets as security, make investments, loans, advances, guarantees and acquisitions, undergo fundamental changes and enter into transactions with affiliates. The Term Loan Agreements also provides that the Company and its subsidiaries on a consolidated basis, meet a Fixed Charge Coverage Ratio as described in detail in the Loan Agreements. The Term Loan Agreements contain events of default that are customary for a facility of this nature, including (subject in certain cases to grace periods and thresholds) nonpayment of principal, nonpayment of interest, fees or other amounts, material inaccuracy of representations and warranties, violation of covenants, cross-default to certain other existing indebtedness, bankruptcy or insolvency events, and certain judgment defaults as specified in the Term Loan Agreements. If an event of default occurs, the maturity of the amounts owed under the Term Loan Agreements may be accelerated. The obligations under the Term Loan Agreements are guaranteed by the Company and IFP and are secured by mortgages on their real estate located in Florida, Illinois, and Pennsylvania and substantially all of their assets, in each case, subject to certain exceptions and permitted liens. The Company recorded a discount to this loan in the amount of $23,367 in connection with financing costs which was amortized to interest expense during the year ended December 31, 2022.

 

On February 14, 2024, The Company sold its Race Track Road Facility in Bonita Springs, Florida, which had been pledged as security for the MapleMark Term Loan 2 (see note 7). Proceeds from the sale in the amount of $352,905 and $910 were used to pay the remaining principal and interest, respectively, on the MapleMark Term Loan 2. At March 31, 2024, there are no amounts due under the MapleMark Term Loan 2.

  $ -     $ 352,905  
                 

A note payable in the amount of $20,000. The Note was due in January 2006 and the Company is currently accruing interest on this note at 1.9%. During the three months ended March 31, 2024, the Company accrued interest in the amount of $96 on this note. At March 31, 2024, accrued interest on this note was $18,578.

  $ 20,000     $ 20,000  

 

Total

  $ 8,982 933     $ 9,358,547  

Discount

    (381,222 )     (382,506 )

Net of discount

  $ 8,601,711     $ 8,976,041  
                 

Current portion

  $ 100,237     $ 121,041  

Long-term maturities, net of discount

    8,501,474       8,855,000  

Total

  $ 8,601,711     $ 8,976,041  

 

There was a total of $93,829 and $95,942 accrued interest on notes payable at March 31, 2024 and December 31, 2023, respectively.

 

20

 

Aggregate maturities of notes payable as of March 31, 2024 are as follows:

 

For the period ended March 31,

 

2025

  $ 120,237  

2026

    110,532  

2027

    121,884  

2028

    134,403  

2029

    148,207  

Thereafter

    8,347,670  

Total

  $ 8,982,933  

 

15. EQUITY

 

Common Stock

 

As of March 31, 2024, total common stock issued and outstanding was 52,516,974 and 49,693,803, respectively. As of December 31, 2023, total common stock issued and outstanding was 52,538,100 and 49,714,929, respectively. At March 31, 2024 and December 31, 2023, a total of 2,823,171 shares of common stock were deemed issued but not outstanding.

 

For the three months ended March 31, 2024:

 

Common Stock Received from Sale of Subsidiary

 

On February 26, 2024, the Company sold 100% of the equity interests in Haley for the return of 21,126 shares of the Company’s common stock held by the buyer. (see note 3). The Company Haley had no assets of liabilities at the time of the sale; the Company valued the 21,126 shares of common stock at the market price on the date of the acquisition of $1.00 per sale and recorded a gain in the amount of $21,126 on this transaction.

 

For the three months ended March 31, 2023:

 

On February 28, 2023, the Company issued 267,030 shares with a value of $112,152 to three employees as compensation.

 

During the three months ended March 31, 2023, the Company incurred obligations to issue the following shares of common stock pursuant to employment agreements: an aggregate total of 400,007 shares of common stock with a market value of $93,600 were accrued for issuance to its previous Chief Executive Officer; of this amount, 207,839 with a market value of $52,919 were withheld for the payment of income taxes, and the net number of shares issuable to the previous Chief Executive Officer was 192,168 with a market value of $45,680. Also during the period, an aggregate total of 15,106 shares of common stock with a market value of $5,000 were accrued for issuance to two board members, and $19,428 was expensed during the quarter for the share based plan for the Chief Executive Officer (see below). These restricted stock grants are being amortized over their vesting periods of one to three years. During the three months ended March 31, 2023, the total amount of $178,048 was charged to non-cash compensation and $52,919 was charged to cash compensation in connection with these grants.

 

21

 

Share based executive compensation plans

 

CEO Stock Plan

 

On February 3, 2023, the Company entered into an employment agreement with Bill Bennett to become the Company’s CEO. On November 3, 2023, the Company recognized that the hiring of Mr. Bennett was protracted, and the original employment agreement calculated the number of Shares to be granted in connection with the Executive Compensation Plan on the basis of the number of Shares outstanding as of October 2022, which did not take into consideration the number of shares that were issued to a departing executive and to certain other employees of the Company thereafter. Accordingly, the number of shares issuable to Mr. Bennett at each price target was adjusted, effective as of the original date of the plan. Pursuant to this agreement, Mr. Bennett was provided with an incentive compensation plan (the “CEO Stock Plan”) whereby Mr. Bennett would be granted shares of the Company’s common stock upon the common stock meeting certain price points at various 60-day volume weighted prices, as described below:

 

       

Number of Shares Granted - Lower of:

 

Stock

   

Number of Shares Issued

   

Maximum

 

Price

   

and Outstanding on

   

Number of

 

Target

   

Grant Date Multiplied by:

   

Shares

 
$ 0.60       2.00 %     975,133  
$ 0.80       1.50 %     731,350  
$ 1.00       1.00 %     487,567  
$ 1.20       0.75 %     365,675  
$ 1.40       0.75 %     365,675  
$ 1.60       0.50 %     243,783  
$ 1.80       0.50 %     243,783  
$ 2.00       0.50 %     243,783  

 

The value of the plan was determined to be $660,541. This amount will be recorded as a charge to additional paid-in capital on a straight-line basis over 34 months. During the three months ended March 31, 2024, the amounts of $58,283 was charged to operations pursuant to the CEO Stock Plan.

 

On November 7, 2023, the Company issued 678,302 shares of common stock, net of 296,831 shares withheld for income tax purposes, to its Chief Executive Officer pursuant the achievement of the first price target in the CEO Stock Plan.

 

On March 19, 2024, the Company’s stock price attained the second price target in the CEO Stock Plan, and Mr. Bennett became eligible to receive 731,350 shares of the Company’s common stock. These shares have not been issued as of March 31, 2024.

 

COO Stock Plan

 

On April 14, 2023, the Company entered into an employment agreement with Brady Smallwood to become the Company’s COO effective May 15, 2023. Pursuant to this agreement, Mr. Smallwood was provided with an incentive compensation plan (the “COO Stock Plan”) whereby Mr. Smallwood would be granted shares of the Company’s common stock upon the common stock meeting certain price points at various 60-day volume weighted prices, as described below:

 

       

Number of Shares Granted - Lower of:

 

Stock

   

Number of Shares Issued

   

Maximum

 

Price

   

and Outstanding on

   

Number of

 

Target

   

Grant Date Multiplied by:

   

Shares

 
$ 0.87       0.40 %     196,627  
$ 1.16       0.30 %     147,470  
$ 1.45       0.20 %     98,313  
$ 1.74       0.15 %     73,735  
$ 2.03       0.15 %     73,735  
$ 2.32       0.10 %     49,157  
$ 2.61       0.10 %     49,157  
$ 2.90       0.10 %     49,157  

 

The value of the plan was determined to be $199,951. This amount will be recorded as a charge to additional paid-in capital on a straight-line basis over 31.5 months. During the three months ended March 31, 2024, the amount of $19,043 was charged to operations pursuant to the COO Stock Plan. At March 31, 2024, none of the price targets under the COO Stock Plan have been achieved.

 

22

 

CFO Stock Plan

 

On December 29, 2023, the Company entered into an employment agreement with Gary Schubert to become the Company’s CFO effective January 1, 2024. Pursuant to this agreement, Mr. Schubert was provided with an incentive compensation plan (the “CFO Stock Plan”) whereby Mr. Schubert would be granted shares of the Company’s common stock upon the common stock meeting certain price points at various 60-day volume weighted prices, as described below:

 

       

Number of Shares Granted - Lower of:

 

Stock

   

Number of Shares Issued

   

Maximum

 

Price

   

and Outstanding on

   

Number of

 

Target

   

Grant Date Multiplied by:

   

Shares

 
$ 1.23       0.40 %     131,085  
$ 1.63       0.30 %     98,313  
$ 2.04       0.20 %     65,542  
$ 2.45       0.15 %     49,157  
$ 2.86       0.15 %     49,157  
$ 3.27       0.10 %     32,771  
$ 3.68       0.10 %     32,771  
$ 4.08       0.10 %     32,771  

 

The CFO Stock Plan had a fair value of $238,747 at inception (see “Stock Plan Valuation” section below). This amount will be amortized over the 30-month life of the plan beginning January 1, 2024. During the three months ended March 31, 2024, $23,875 of this amount was charged to operations. At March 31, 2024, none of the price targets under the COO Stock Plan have been achieved.

 

The Company relied upon the guidance of Statement of Financial Account Standards No. 718 Compensation – Stock Compensation (“ASC 718”) in accounting for the CEO, COO, and CFO Stock Plans. A Monte Carlo market-based performance stock awards model was used in valuing the plan, with the following assumptions:

 

 

The stock price for each trading day would fluctuate with an estimated projected volatility using a normal distribution. The stock price of the underlying instrument is modeled such that it follows a geometric Brownian motion with constant drift and volatility.

 

 

 

 

The Company would award the stock upon triggering the thresholds.

 

 

 

 

Annual attrition or forfeiture rates (i.e., pre–vesting forfeiture assumption) are assumed to be zero given the Holder’s position with the Company.

 

 

 

 

No Projected capital events were included in the adjustments to the shares issued and outstanding in the projected simulations.

 

 

 

 

Awards/Payouts were discounted at the risk–free rate.

 

The CEO, COO, and CFO Stock Plans were valued utilizing the following:

 

   

December 31, 2023

Volatility

    103.9%-113.7%

Dividends

  $ 0 

Risk-free interest rates

    4.45%-4.45%

Expected term (years)

    2.63-2.91 

 

Stock Appreciation Rights

 

Effective May 15, 2023, the Company issued 1,500,000 stock appreciation rights (the “Smallwood SARs”) to Brady Smallwood, its Chief Operating Officer. The Smallwood SARs vest upon issuance, and expire on December 31, 2026; 750,000 of the Smallwood SARs are priced at $1.50 per share, and 750,000 are priced at $2.00 per share. It is the Company’s intention to settle the Smallwood SARs in cash if the stock price exceeds the $1.50 and $2.00 per share price prior to the expiration date. The Smallwood SARs were valued utilizing the Black-Scholes valuation model, and had an aggregate fair value of $9,794 upon issuance; this amount was charged to operations and credited to stock appreciation rights liability. The Smallwood SARs are revalued each quarter, and any gain or loss in the fair value is charged to non-cash compensation expense. At March 31, 2024, the Smallwood SARs had a fair value of $373,918; the increase in fair value in the amount $118,898 during the three months ended March 31, 2024 was charged to non-cash compensation. See note 13.

 

23

 

The Smallwood SARs were valued using the Black-Scholes valuation model utilizing the following variables:

 

   

March 31,

   

December 31,

 
   

2024

   

2023

 

Volatility

    86.58 %     45.0-53.3 %

Dividends

  $ -     $ -  

Risk-free interest rates

    4.59 %     3.67-4.87 %

Term (years)

    2.75       2.63-2.51  

 

Options

 

The following table summarizes the options outstanding at March 31, 2024 and the related prices for the options to purchase shares of the Company’s common stock issued by the Company:

 

                       

Weighted

           

Weighted

 
               

Weighted

   

average

           

average

 
               

average

   

exercise

           

exercise

 

Range of

   

Number of

   

Remaining

   

price of

   

Number of

   

price of

 

exercise

   

options

   

contractual

   

outstanding

   

options

   

exercisable

 

Prices

   

Outstanding

   

life (years)

   

Options

   

Exercisable

   

Options

 
$ 0.41       125,000       0.07     $ 0.41       125,000     $ 0.41  
$ 0.50       125,000       0.07     $ 0.50       125,000     $ 0.50  
$ 0.60       50,000       1.75     $ 0.60       43,750     $ 0.60  
$ 1.00       50,000       1.75     $ 1.00       43,750     $ 1.00  
$ 1.25       130,000       2.25     $ 1.25       -     $ -  
$ 1.75       130,000       2.25     $ 1.75       -     $ -  
          610,000       1.27     $ 0.96       350,000     $ 0.55  

 

Transactions involving stock options are summarized as follows:

 

   

Number of Shares

   

Weighted Average

Exercise Price

 

Options outstanding at December 31, 2023

    350,000     $ 0.55  
                 

Granted

    260,000     $ 1.50  

Exercised

    -     $ -  

Cancelled / Expired

    -     $ -  
                 

Options outstanding at March 31, 2024 (unaudited)

    610,000     $ 0.96  

Options exercisable at March 31, 2024 (unaudited)

    350,000     $ 0.55  

 

Aggregate intrinsic value of options outstanding and exercisable at March 31, 2024 was $156,075. Aggregate intrinsic value represents the difference between the Company’s closing stock price on the last trading day of the fiscal period, which was $1.00 at March 31, 2024, and the exercise price multiplied by the number of options outstanding.

 

During the three months ended March 31, 2024 and 2023, the Company charged the amount of $2,034 and $0, respectively, to operations for the vesting of stock options.

 

24

 

16. RELATED PARTY TRANSACTIONS

 

Payments to Prior Executive Officers under Separation Agreements

 

During the three months ended March 31, 2024, the Company made the following payments to previous Executive Officers in connection with separation agreements (see note 12):

 

The Company paid cash in the amount of $83,333 to Mr. Klepfish, its prior CEO.

 

The Company made Cobra payments on behalf of Mr. Weirnasz, its prior Director of Strategic Acquisitions and previous board member, in the amount of $967.

 

The Company made cash payments to Mr. Tang, its prior CFO, in the amount of $41,125, and made Cobra payments on behalf of Mr. Tang in the amount of $2,885.

 

17. MAJOR CUSTOMERS

 

The Company’s largest customer, U.S. Foods, Inc. and its affiliates, accounted for approximately 49% and 47% of total sales in the three months ended March 31, 2024 and 2023, respectively. In addition, Gate Gourmet, the leading global provider of airline catering solutions and provisioning services for airlines, in partnership with igourmet, represented 17% and 16% of total sales for the three months ended March 31, 2024 and 2023, respectively.

 

18. COMMITMENTS AND CONTINGENCIES

 

Litigation

 

On September 16, 2019, an action (the “PA Action”) was filed in the Court of Common Pleas of Philadelphia County, Trial Division, against, among others, the Company and its wholly-owned subsidiaries, igourmet and Food Innovations, Inc. On January 5, 2024, all parties to the PA Action came to an agreement at Mediation on the material terms of settlement and on January 22, 2024, a settlement was agreed upon in an action filed in the Court of Common Pleas of Philadelphia County, Trial Division against, among others, the Company and its wholly owned subsidiaries, igourmet and Food Innovations, Inc. On Monday, January 29, 2024, the Company received a settlement and release agreement from certain plaintiffs in the PA Action. The Company and its subsidiaries resolved all liabilities within the coverages of their insurance carriers.

 

From time to time, the Company has become and may become involved in certain lawsuits and legal proceedings which arise in the ordinary course of business, or as the result of current or previous investments, or current or previous subsidiaries, or current or previous employees, or current or previous directors, or as a result of acquisitions and dispositions or other corporate activities. The Company intends to vigorously defend its positions. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our financial position or our business and the outcome of these matters cannot be ultimately predicted.

 

19. SUBSEQUENT EVENTS

 

Share Incentive Plan Performance Goal Achieved

 

On April 17, 2024, the Company’s stock price achieved the first price target of $0.87 under the COO Stock Plan and the Company became obligated to issue a total of 196,627 shares to its COO.

 

25

 

ITEM 2 - MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

FORWARD LOOKING STATEMENTS

 

The following discussion should be read in conjunction with the consolidated financial statements and the related notes thereto, as well as all other related notes, and financial and operational references, appearing elsewhere in this document.

 

Certain information contained in this discussion and elsewhere in this report may include “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, and is subject to the safe harbor created by that act. The safe harbor created by the Private Securities Litigation Reform Act will not apply to certain “forward looking statements” because we issued “penny stock” (as defined in Section 3(a)(51) of the Securities Exchange Act of 1934 and Rule 3(a)(51-1) under the Exchange Act) during the three year period preceding the date(s) on which those forward looking statements were first made, except to the extent otherwise specifically provided by rule, regulation or order of the Securities and Exchange Commission. We caution readers that certain important factors may affect our actual results and could cause such results to differ materially from any forward-looking statements which may be deemed to have been made in this Report or which are otherwise made by or on our behalf. For this purpose, any statements contained in this report that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as “may”, “will”, “expect”, “believe”, “explore”, “consider”, “anticipate”, “intend”, “could”, “estimate”, “plan”, “propose” or “continue” or the negative variations of those words or comparable terminology are intended to identify forward-looking statements. Factors that may affect our results include, but are not limited to, the risks and uncertainties associated with:

 

Our ability to raise capital necessary to sustain our anticipated operations and implement our business plan,

 

 

Our ability to implement our business plan,

 

 

Our ability to generate sufficient cash to pay our lenders and other creditors,

 

 

Our dependence on one major customer,

 

 

Our ability to employ and retain qualified management and employees,

 

 

Our dependence on the efforts and abilities of our current employees and executive officers,

 

 

Changes in government regulations that are applicable to our current or anticipated business,

 

 

Changes in the demand for our services and different food trends,

 

 

The degree and nature of our competition,

 

 

The lack of diversification of our business plan,

 

 

The general volatility of the capital markets and the establishment of a market for our shares, and

 

 

Disruption in the economic and financial conditions primarily from the impact of past terrorist attacks in the United States, threats of future attacks, police and military activities overseas and other disruptive worldwide political and economic events, health pandemics, rising inflation and energy costs, and environmental weather conditions.

 

We are also subject to other risks detailed from time to time in our other filings with the SEC and elsewhere in this report. Any one or more of these uncertainties, risks and other influences could materially affect our results of operations and whether forward-looking statements made by us ultimately prove to be accurate. Our actual results, performance and achievements could differ materially from those expressed or implied in these forward-looking statements. We undertake no obligation to publicly update or revise any forward-looking statements, whether from new information, future events or otherwise.

 

26

 

Critical Accounting Policy and Estimates

 

Use of Estimates in the Preparation of Financial Statements

 

The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. These estimates include certain assumptions related to, among others, doubtful accounts receivable, valuation of stock-based services, operating right of use assets and liabilities, and income taxes. On an on-going basis, we evaluate these estimates, including those related to revenue recognition and concentration of credit risk. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Accounts subject to estimate and judgements are accounts receivable reserves, income taxes, intangible assets, contingent liabilities, and equity-based instruments. Actual results may differ from these estimates under different assumptions or conditions. We believe our estimates have not been materially inaccurate in past years, and our assumptions are not likely to change in the foreseeable future.

 

Provision for Doubtful Accounts Receivable

 

The Company provides an allowance for doubtful accounts equal to the estimated uncollectible amounts pursuant to the guidance of Accounting Standards Update (ASU) 2016-13, Financial Instruments – Credit Losses (Topic 326) as codified in Accounts Standards Codification (ASC) 326, Financial Instruments – Credit Losses. Under ASC 326, the Company utilizes a current and expected credit loss (CECL) impairment model. ASU 2016-13 became effective for us on January 1, 2023. The Company’s estimate is based on historical collection experience and a review of the current status of trade accounts receivable. It is reasonably possible that the Company’s estimate of the allowance for doubtful accounts will change. Accounts receivable are presented net of an allowance for doubtful accounts of $69,359 and $46,477 at March 31, 2024 and December 31, 2023, respectively.

 

Fair Value of Financial Instruments

 

The Company measures its financial assets and liabilities in accordance with accounting principles generally accepted in the United States of America. The estimated fair values approximate their carrying value because of the short-term maturity of these instruments or the stated interest rates are indicative of market interest rates. These fair values have historically varied due to the market price of the Company’s stock at the date of valuation.

 

Income Taxes

 

The Company uses the liability method of accounting for income taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to financial statements carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards. The measurement of deferred tax assets and liabilities is based on provisions of applicable tax law. The measurement of deferred tax assets is reduced, if necessary, by a valuation allowance based on the amount of tax benefits that, based on available evidence, is not expected to be realized.

 

Leases

 

The Company determines if an arrangement is a lease at inception. Operating lease right-of-use assets (“ROU assets”) and short-term and long-term lease liabilities are included on the face of the condensed consolidated balance sheet. Finance lease ROU assets are presented within other assets, and finance lease liabilities are presented within accrued liabilities.

 

ROU assets represent the right of use to an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The operating lease ROU asset also excludes lease incentives. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. The Company has lease agreements with lease and non-lease components, which are accounted for as a single lease component. For lease agreements with terms less than 12 months, the Company has elected the short-term lease measurement and recognition exemption, and it recognizes such lease payments on a straight-line basis over the lease term.

 

27

 

Our Business Activities

 

Innovative Food Holdings (IVFH) builds dynamic scalable businesses by selling specialty foods that are difficult to find through traditional channels. Our expertise is forging close relationships with the producers, growers, makers and distributors of specialty products, then carefully selecting our suppliers based on their quality, uniqueness and reliability.

 

The IVFH team is adept at evaluating and certifying the food safety and supply chain capabilities of small batch producers who don’t typically sell through broad-based sales channels. We seek out the freshest, most unique, origin-specific gourmet cheese, meat, produce, and premium ingredients available, and distribute them directly from our robust network of vendors and warehouses within 24 – 72 hours of an order being placed. We also source, package, and brand a meaningful segment of these products ourselves, enabling us to better control the assortment, offer more flexibility and variety to our customers, and capture additional margin.

 

We leverage this unique, premium assortment to serve the needs of Professional Chefs in settings such as restaurants, hotels, country clubs, national chain accounts, casinos, hospitals and catering houses. We provide these premium customers with products that can’t typically be found through their broadline distributor’s warehouse assortment. We distribute these products directly to Professional Chefs in Chicago through our subsidiary, Artisan Specialty Foods, Inc., and nationally through our e-commerce businesses on Amazon.com and our own website. We also drop ship specialty foods to Professional Chefs nationally through the websites of broadline distributors, such as US Foods, Inc. Between this variety of sales channels, IVFH is able to serve our Professional Chef customers wherever they are located.

 

We have made the strategic decision to sell our 200K square foot facility in Mountain Top, Pennsylvania and consolidate our warehouse activities into our 28K square foot facility in the greater Chicago area. We have the capabilities to pack and ship frozen, refrigerated, and ambient products, enabling us to sell a broad range of specialty foods. We also have GFSI/SQF certifications, allowing compatibility with the highest standards of food handling supply chains in the world, and the quality and food safety that our premium customers expect from us. These warehouses have the ability to ship packages and pallets of all sizes through overnight shipping. We also leverage our own fleet of trucks to deliver directly to our Professional Chef customers within our reach.

 

Our proprietary technology platform underpins our entire business, driving transparency and efficiency up and down the supply chain. Orders flow in real time, whether to our warehouses or to our vendor partners, to allow for fast handling and fulfillment. Our picking is enabled by efficient scan-based, handheld devices, ensuring order and inventory accuracy. Our warehouse management software optimizes pick routes for common items and order types, recommends a box size, and calculates the appropriate amount of packaging and ice required based on forecasted temperatures along the delivery route.

 

We have built a team consisting of passionate, committed, and food-obsessed people: our average tenure (outside of seasonal workers) across the company is over five years. Our merchandising team has deep connections within the specialty food space around the globe. Our Chef Advisors, as ex-chefs themselves, go beyond customer service to offer our Professional Chefs customer support, menu ideas, and preparation guidance.

 

RESULTS OF OPERATIONS

 

This discussion may contain forward looking statements that involve risks and uncertainties. Our future results could differ materially from the forward looking statements discussed in this report. This discussion should be read in conjunction with our consolidated financial statements, the notes thereto and other financial information included elsewhere in the report.

 

Three Months Ended March 31, 2024 Compared to Three Months Ended March 31, 2023

 

Revenue

 

Revenue decreased by $1.0 million or approximately 5.7% to $15.7 million for the three months ended March 31, 2024 from $16.7 million in the prior year. These revenue declines were driven primarily by our consumer eCommerce business sales declining by 41.7%, as we began the ramp-down of the business. In fact, this shift of focus to our Specialty Foodservice business has already begun to make an impact.  After several quarters of decline our Specialty Foodservice business sales grew by 1.4%. While we expect this Specialty Foodservice revenue to generate positive growth for the year, Q2 will likely be our toughest quarter.   As we’ve said previously, the B2B sales cycle is long, but we remain optimistic in how our sales efforts are progressing.  Shortly after the close of the first quarter, we announced the signing of a contract with a new customer, Cheney Brothers, and conversations with other large potential customers continue. Within our Specialty Foodservice business, we also continue to build out our sourcing efforts, significantly ramping up the pace of our vendor and item onboarding, which we also expect to begin to contribute to revenue growth in the back half of 2024. 

 

28

 

Any changes in the food distribution and specialty foods operating landscape that materially hinders our current ability and/or cost to deliver our products to our customers could potentially cause a material impact on our net revenue and gross margin and, therefore, our profitability and cash flows could be adversely affected.

 

We also saw a decrease in our logistics business (from $248,569 in the three months ended March 31, 2023 to $208,211 in the three months ended March 31, 2024) as our existing customers experienced softness in demand and subsequently less volume throughput for our logistics services. Though small, we continue to seek new opportunities to leverage our logistics services in order to better leverage existing fixed assets.

 

Currently, a small portion of our revenues comes from imported products or international sales. Our current sales from such markets may be hampered and negatively impacted by any economic tariffs that may be imposed in the United States or in foreign countries.

 

See “Transactions with Major Customers” and the Securities and Exchange Commission’s (“SEC”) mandated FR-60 disclosures following the “Liquidity and Capital Resources” section for a further discussion of the significant customer concentrations, loss of significant customer, critical accounting policies and estimates, and other factors that could affect future results.

 

Cost of goods sold

 

Our cost of goods sold for the three months ended March 31, 2024 was $11.9 million, a decrease of $1.0 million or approximately 7.8% compared to cost of goods sold of $12.9 million for the three months ended March 31, 2023. Cost of goods sold was made up of the following expenses for the three months ended March 31, 2024: cost of goods in the amount of $9.1 million ; and shipping, delivery, handling, and purchase allowance expenses in the amount of $2.8 million. Gross margins as a percentage of sales increased during the current period to 24.4% compared to 22.6% during the comparable period, an improvement of 174 basis points, as we continued implementing our strategy to improve cost controls, better manage pricing, and focus more on product mix.  Importantly, the improvement was driven by an improvement in gross margins in the Specialty Foodservice business.  The enhancement in our financial performance was significantly influenced by the increased gross margins within our Specialty Foodservice sector. Additionally, our deliberate shift away from a pricier shipping supplier served to further elevate our margin levels.

 

Selling, general, and administrative expenses

 

Selling, general, and administrative expenses (“SG&A”) decreased by $0.4 million or 9.7% to $4.0million during the three months ended March 31, 2024 compared to $4.4 million for the three months ended March 31, 2023. The decrease in selling, general, and administrative expenses was primarily due to a decrease in legal and professional fees of $0.2 million, a decrease in advertising of $0.2 million, and a decrease in payroll and related costs of $0.1 million.  These decreases were partially offset by an increase in real estate commissions of $0.1 million related to the sale of the Race Track Road Facility. Selling, general, and administrative expenses as a percentage of sales increased from 26.7% of sales during the three months ended March 31, 2023 to 25.5% of sales during the current quarter.

 

Separation costs – executive officers

 

During the three months ended March 31, 2023, the Company entered into a separation agreement with its Prior CEO and current board member with a total cost of $1,819,199 consisting of $1,251,199 in cash payments, $1,199 of Cobra health insurance payments, and stock grants with a value of $568,000. Also, during the three months ended March 31, 2023, the Company entered into a separation agreement with its prior Director of Strategic Acquisitions and board member consisting of cash payments of $100,000 and $26,451 of Cobra health insurance payments. The aggregate separation costs charged to operations during the three months ended March 31, 2023 was $1,945,650; there were no such costs during the current period.

 

Interest expense, net

 

Interest expense, net of interest income, increased by $42,729 or approximately 24.7% to $215,450 during the three months ended March 31, 2024, compared to $172,721 during the three months ended March 31, 2023. The increase was due to an increase in interest accrued or paid on the Company’s commercial loans and notes payable in the amount of $54,367 due to higher interest rates and higher balances under the MapleMark term loans, backed by the USDA. Interest expense also increased due to an increase in the amortization of prepaid loan fees in the amount of $1,283. This increase was partially offset by an increase in interest income in the amount of $12,921.

 

29

 

Gain on sale of assets

 

During the three months ended March 31, 2024, the Company sold its property located in Bonita Springs, Florida for a gain in the amount of $1,807,516. There was no comparable transaction in the prior period.

 

Gain on sale of subsidiary

 

During the three months ended March 31, 2024, the Company sold its subsidiary Haley Group, Inc.; consideration for the sale was the return to the Company of 21,126 shares of the Company’s common stock with a market value at the time of the sale of $21,126. The Company recorded a gain on the sale of Haley in the amount of $21,126. There was no comparable transaction in the prior period.

 

Other leasing income

 

During the three months ended March 31, 2024 and March 31, 2023, the Company recognized income in the amount of $1,900 in connection with the lease of space in our Mountaintop warehouse facility.

 

Net income (loss) from continuing operations

 

For the reasons above, the Company had net income from continuing operations for the three months ended March 31, 2024 of $1.4 million  compared to a net loss from continuing operations of $(2.8) million during the three months ended March 31, 2023. The net income from continuing operations for the three months ended March 31, 2024 includes a net total of $354,524 in non-cash charges: non-cash compensation in the amount of $220,099, depreciation and amortization expense of $110,260, provision for doubtful accounts of $22,882, and amortization of the discount on notes payable term loans of $1,283. The net loss from continuing operations for the three months ended March 31, 2023 includes a total of $328,101 in non-cash charges, including non-cash compensation in the amount of $178,048, depreciation and amortization expense of $145,387, and provision for doubtful accounts of $4,666.

 

Net loss from discontinued operations

 

For the three months ended March 31, 2024, the Company had a net loss from discontinued operations in the amount of $10,105, a decrease in the amount of $31,946 or approximately 76% compared to a net loss from discontinue operations in the amount of $42,051 for the three months ended March 31, 2023.

 

Liquidity and Capital Resources at March 31, 2024

 

As of March 31, 2024, the Company had current assets of $17,533,707, consisting of cash and cash equivalents of $4,272,243, trade accounts receivable, net, of $4,109,274, inventory of $2,840,682, other current assets of $348,926, assets held for sale of $5,941,933, and current assets – discontinued operations of $20,649. Also at March 31, 2024, the Company had current liabilities of $5,482,266, consisting of trade payables and accrued liabilities of $3,111,671, current portion of accrued separation costs – related parties of $418,635, accrued interest of $93,829, deferred revenue of $1,227,936, liability for stock appreciation rights of $373,918, current portion of notes payable of $100,237, current portion of operating lease liability of $17,422, current portion of financing lease liability of $136,096, and current liabilities - discontinued operations of $2,522.

 

During the three months ended March 31, 2024, the Company had cash used in operating activities of $3,157,213. Cash flow used in operations consisted of the Company’s consolidated net income of $1,425,874 less gain on disposition of assets of $1,807,516 and gain on sale of subsidiary of $21,126, plus non-cash charges for depreciation and amortization of $110,260, increase in value of stock appreciation rights of $118,898, stock-based compensation in the amount of $103,325, provision for doubtful accounts of $22,882, amortization of right-of-use assets of $4,175, and amortization of discount on notes payable of $1,283. The Company’s cash position also decreased by $3,115,178 as a result of changes in the components of current assets and current liabilities, primarily the result of a net paydown of $3,114,335 in accounts payable and accrued liabilities. Excluding $128,610 in payments associated with the separation and hiring of key officers referenced earlier, the Company would have recorded cash used in operating activities of $3,028,603 for the three months ended March 31, 2024, an improvement of $128,608 compared to the three months ended March 31, 2023.

 

The Company had cash provided by investing activities of $2,099,779 for the three months ended March 31, 2024, which consisted of cash received from the sale of our Bonita Springs property in the amount of $2,101,185 net of the payoff of the related secured loan in the amount of $353,815 including accrued interest. The Company also purchased property and equipment in the amount of $1,406 during the period.

 

30

 

The Company had cash used in financing activities of $72,685 for the three months ended March 31, 2024, which consisted of payments on notes payable and financing lease in the amount of $22,708 and $49,977, respectively.

 

At March 31, 2024, we had positive net working capital in the amount of $12,051,441 compared to net working capital of $5,000,156 at the December 31, 2023, an improvement of $7,051,285. The Company reported a profit from continuing operations in the amount of $1,435,979 for the three months ended March 31, 2024 compared to a loss from continuing operations of $2,786,715 during the comparable period of the prior year. In addition, the Company continues to maintain the untapped $3 million revolver with MapleMark. Due to the Company’s improved operations performance along with its restructured balance sheet, we believe that any issues regarding our near-term liquidity have been resolved.

 

During 2024, management is focused on continuing the Stabilization phase of its three phase plan, focusing on the fundamentals of running a cash flow positive business, serving Professional Chefs, including a focus on improving margins. Management expects to continue to expand the Professional Chefs business by entering additional specialty foods markets, serving new customers, and launching new products. On the Home Gourmet business, management has kicked off the marketing of the business for divestiture, and in the meantime has eliminated all marketing spend, reduced headcount, and eliminated unproductive inventory.

 

No assurances can be given that any of these plans will come to fruition or that if implemented they will necessarily yield positive results.

 

Transactions with Major Customers

 

Transactions with a major customer and related economic dependence information is set forth below and following our discussion of Liquidity and Capital Resources.

 

The Company’s largest customer, U.S. Foods, Inc. and its affiliates, accounted for approximately 49% and 47% of total sales in the three months ended March 31, 2024 and 2023, respectively. In addition, Gate Gourmet, the leading global provider of airline catering solutions and provisioning services for airlines, in partnership with igourmet, represented 16% of total sales for the three months ended March 31, 2024 and 2023.

 

Off-Balance Sheet Arrangements

 

We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues, or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

 

31

 

Inflation

 

In the opinion of management, inflation has had a material effect on the Company’s financial condition and results of its operations. The Company has seen the impact of inflation across its costs for fuel, shipping, cost of goods, and marketing. Balancing the management of these increases with the willingness of our customers to pay higher prices will continue to be a key focus for the Company this year. However, no assurance can be given that we will be successful and inflationary pressure on our profits will likely continue through 2024.

 

RISK FACTORS

 

The Company’s business and success is subject to numerous risk factors as detailed in its Annual Report on Form 10-K for the year ended December 31, 2023 and other of its Current Reports on Form 8-K, all of which reports are available at no cost at www.sec.gov.

 

ITEM 4 - CONTROLS AND PROCEDURES

 

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed by us in the reports that we file or submit pursuant to the requirements of the Securities Exchange Act of 1934 is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, among other things, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file under the Exchange Act is accumulated and communicated to our management, including our principal executive and financial officers, as appropriate, to allow timely decisions regarding required disclosure.

 

(a) Evaluation of disclosure controls and procedures

 

Our Principal Executive Officer and Principal Financial Officer, after evaluating the effectiveness of our disclosure controls and procedures (as defined as defined in Rule 13a-15(f) and 15d-(f) under the Exchange Act.) as of the end of the period covered by this Quarterly Report, have determined that our controls and procedures are effective at March 31, 2024 at the reasonable assurance level. In making this assessment, our management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) in Internal Control-Integrated Framework (2013).

 

(b) Changes in internal control over financial reporting

 

There were no changes in our internal control over financial reporting identified in connection with the evaluation required by Exchange Act Rules 13a-15(d) and 15d-15 that occurred during the period covered by this Quarterly Report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

32

 

PART II. OTHER INFORMATION

 

Item 1. Legal Proceedings

 

On September 16, 2019, an action (the “PA Action”) was filed in the Court of Common Pleas of Philadelphia County, Trial Division, against, among others, the Company and its wholly-owned subsidiaries, igourmet and Food Innovations, Inc. On January 5, 2024, all parties to the PA Action came to an agreement at Mediation on the material terms of settlement and on January 22, 2024, a settlement was agreed upon in an action filed in the Court of Common Pleas of Philadelphia County, Trial Division against, among others, the Company and its wholly owned subsidiaries, igourmet and Food Innovations, Inc. On Monday, January 29, 2024, the Company received a settlement and release agreement from certain plaintiffs in the PA Action. The Company and its subsidiaries resolved all liabilities within the coverages of their insurance carriers.

 

From time to time, the Company has become and may become involved in certain lawsuits and legal proceedings which arise in the ordinary course of business, or as the result of current or previous investments, or current or previous subsidiaries, or current or previous employees, or current or previous directors, or as a result of acquisitions and dispositions or other corporate activities. The Company intends to vigorously defend its positions. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our financial position or our business, and the outcome of these matters cannot be ultimately predicted.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

None.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

Item 5. Other Information

 

None

 

33

 

Item 6. Exhibits

 

3.1

Articles of Incorporation (incorporated by reference to exhibit 3.1 of the Company’s annual report on Form 10-KSB for the year ended December 31, 2004 filed with the Securities and Exchange Commission on September 28, 2005).

 

 

3.2

Amended Bylaws of the Company (incorporated by reference to exhibit 3.2 of the Company’s annual report Form 10-K for the year ended December 31, 2010 filed with the Securities and Exchange Commission on March 16, 2011).

 

 

3.2.1

Amended Bylaws of the Company (incorporated by reference to exhibit 3.1 of the Company’s current report Form 8-K filed with the Securities and Exchange Commission on March 13, 2023).

 

 

10.1

Executive Employment Agreement dated February 3, 2023 between the Registrant and Robert William Bennett (incorporated by reference to exhibit 10.1 of the Company’s current report Form 8-K filed with the Securities and Exchange Commission on February 7, 2023)

 

 

10.2

Agreement and General Release dated February 3, 2023 between the Registrant and Samuel Klepfish (incorporated by reference to exhibit 10.2 of the Company’s current report Form 8-K filed with the Securities and Exchange Commission on February 7, 2023)

 

 

10.3

Side Letter dated February dated February 3, 2023 between the Registrant and Samuel Klepfish (incorporated by reference to exhibit 10.3 of the Company’s current report Form 8-K filed with the Securities and Exchange Commission on February 7, 2023)

 

 

31.1

Section 302 Certification

 

 

31.2

Section 302 Certification

 

 

32.1

Section 906 Certification

 

 

32.2

Section 906 Certification

 

 

101.INS

Inline XBRL Instance Document

 

 

101.SCH

Inline XBRL Taxonomy Extension Schema

 

 

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase

 

 

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase

 

 

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase

 

 

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase

 

 

104

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

34

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

SIGNATURE

 

TITLE

 

DATE

 

 

 

 

 

/s/ Robert William Bennett

 

Chief Executive Officer and Director

 

May 14, 2024

Robert William Bennett

 

(Principal Executive Officer)

 

 

 

 

 

 

 

/s/ Gary Schubert

 

Chief Financial Officer

 

May 14, 2024

Gary Schubert

 

 

 

 

 

35
NONE false --12-31 Q1 0000312257 0000312257 2024-01-01 2024-03-31 0000312257 2024-05-13 0000312257 2024-03-31 0000312257 2023-12-31 0000312257 2023-01-01 2023-03-31 0000312257 us-gaap:CommonStockMember 2022-12-31 0000312257 ivfh:CommonStockToBeIssuedMember 2022-12-31 0000312257 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000312257 us-gaap:TreasuryStockCommonMember 2022-12-31 0000312257 us-gaap:RetainedEarningsMember 2022-12-31 0000312257 2022-12-31 0000312257 ivfh:CommonStockToBeIssuedMember 2023-01-01 2023-03-31 0000312257 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0000312257 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0000312257 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0000312257 us-gaap:CommonStockMember 2023-03-31 0000312257 ivfh:CommonStockToBeIssuedMember 2023-03-31 0000312257 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0000312257 us-gaap:TreasuryStockCommonMember 2023-03-31 0000312257 us-gaap:RetainedEarningsMember 2023-03-31 0000312257 2023-03-31 0000312257 us-gaap:CommonStockMember 2023-12-31 0000312257 ivfh:CommonStockToBeIssuedMember 2023-12-31 0000312257 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000312257 us-gaap:TreasuryStockCommonMember 2023-12-31 0000312257 us-gaap:RetainedEarningsMember 2023-12-31 0000312257 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0000312257 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0000312257 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0000312257 us-gaap:CommonStockMember 2024-03-31 0000312257 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000312257 us-gaap:TreasuryStockCommonMember 2024-03-31 0000312257 us-gaap:RetainedEarningsMember 2024-03-31 0000312257 ivfh:USFoodsIncMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0000312257 ivfh:USFoodsIncMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0000312257 ivfh:USFoodsIncMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0000312257 ivfh:USFoodsIncMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0000312257 us-gaap:RestrictedStockMember 2024-03-31 0000312257 us-gaap:RestrictedStockMember 2024-01-01 2024-03-31 0000312257 us-gaap:RestrictedStockMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2024-01-01 2024-03-31 0000312257 us-gaap:RestrictedStockMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2024-03-31 0000312257 us-gaap:RestrictedStockMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2024-01-01 2024-03-31 0000312257 srt:ChiefExecutiveOfficerMember 2024-01-01 2024-03-31 0000312257 us-gaap:RestrictedStockMember 2023-03-31 0000312257 us-gaap:RestrictedStockMember 2023-01-01 2023-03-31 0000312257 us-gaap:RestrictedStockMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2023-01-01 2023-03-31 0000312257 us-gaap:RestrictedStockMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2023-03-31 0000312257 us-gaap:RestrictedStockMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2023-01-01 2023-03-31 0000312257 srt:ChiefExecutiveOfficerMember 2023-01-01 2023-03-31 0000312257 ivfh:SpecialtyFoodServicesMember 2024-01-01 2024-03-31 0000312257 ivfh:SpecialtyFoodServicesMember 2023-01-01 2023-03-31 0000312257 ivfh:EcommerceMember 2024-01-01 2024-03-31 0000312257 ivfh:EcommerceMember 2023-01-01 2023-03-31 0000312257 ivfh:WarehouseAndLogisticServicesMember 2024-01-01 2024-03-31 0000312257 ivfh:WarehouseAndLogisticServicesMember 2023-01-01 2023-03-31 0000312257 ivfh:OptionsAt041Member 2024-01-01 2024-03-31 0000312257 ivfh:OptionsAt041Member 2024-03-31 0000312257 ivfh:OptionsAt050Member 2024-01-01 2024-03-31 0000312257 ivfh:OptionsAt050Member 2024-03-31 0000312257 ivfh:OptionsAt060Member 2024-01-01 2024-03-31 0000312257 ivfh:OptionsAt060Member 2024-03-31 0000312257 ivfh:OptionsAt100Member 2024-01-01 2024-03-31 0000312257 ivfh:OptionsAt100Member 2024-03-31 0000312257 ivfh:OptionsAt125Member 2024-01-01 2024-03-31 0000312257 ivfh:OptionsAt125Member 2024-03-31 0000312257 ivfh:OptionsAt175Member 2024-01-01 2024-03-31 0000312257 ivfh:OptionsAt175Member 2024-03-31 0000312257 ivfh:OptionsAt041Member 2023-01-01 2023-03-31 0000312257 ivfh:OptionsAt041Member 2023-03-31 0000312257 ivfh:OptionsAt050Member 2023-01-01 2023-03-31 0000312257 ivfh:OptionsAt050Member 2023-03-31 0000312257 ivfh:OptionsAt060Member 2023-01-01 2023-03-31 0000312257 ivfh:OptionsAt060Member 2023-03-31 0000312257 ivfh:OptionsAt062Member 2023-01-01 2023-03-31 0000312257 ivfh:OptionsAt062Member 2023-03-31 0000312257 ivfh:OptionsAt085Member 2023-01-01 2023-03-31 0000312257 ivfh:OptionsAt085Member 2023-03-31 0000312257 ivfh:OptionsAt100Member 2023-01-01 2023-03-31 0000312257 ivfh:OptionsAt100Member 2023-03-31 0000312257 ivfh:OptionsAt120Member 2023-01-01 2023-03-31 0000312257 ivfh:OptionsAt120Member 2023-03-31 0000312257 us-gaap:SegmentDiscontinuedOperationsMember 2024-03-31 0000312257 us-gaap:SegmentDiscontinuedOperationsMember 2023-12-31 0000312257 us-gaap:SegmentDiscontinuedOperationsMember 2024-01-01 2024-03-31 0000312257 us-gaap:SegmentDiscontinuedOperationsMember 2023-01-01 2023-03-31 0000312257 ivfh:HaleyFoodGroupIncMember 2024-02-26 0000312257 ivfh:HaleyFoodGroupIncMember 2024-02-26 2024-02-26 0000312257 2024-02-26 2024-02-26 0000312257 2024-02-26 0000312257 us-gaap:LandMember 2024-03-31 0000312257 us-gaap:LandMember 2023-12-31 0000312257 us-gaap:BuildingMember 2024-03-31 0000312257 us-gaap:BuildingMember 2023-12-31 0000312257 us-gaap:ComputerEquipmentMember 2024-03-31 0000312257 us-gaap:ComputerEquipmentMember 2023-12-31 0000312257 us-gaap:EquipmentMember 2024-03-31 0000312257 us-gaap:EquipmentMember 2023-12-31 0000312257 us-gaap:FurnitureAndFixturesMember 2024-03-31 0000312257 us-gaap:FurnitureAndFixturesMember 2023-12-31 0000312257 us-gaap:VehiclesMember 2024-03-31 0000312257 us-gaap:VehiclesMember 2023-12-31 0000312257 ivfh:RaceTrackRoadPropertyMember 2024-02-14 2024-02-14 0000312257 us-gaap:LandMember 2024-03-31 0000312257 us-gaap:LandMember 2023-12-31 0000312257 us-gaap:BuildingMember 2024-03-31 0000312257 us-gaap:BuildingMember 2023-12-31 0000312257 us-gaap:FurnitureAndFixturesMember 2024-03-31 0000312257 us-gaap:FurnitureAndFixturesMember 2023-12-31 0000312257 srt:MinimumMember 2024-03-31 0000312257 srt:MaximumMember 2024-03-31 0000312257 us-gaap:OfficeEquipmentMember 2024-03-31 0000312257 us-gaap:OfficeEquipmentMember 2023-12-31 0000312257 ivfh:FinanceLease6Member 2024-03-31 0000312257 ivfh:FinanceLease6Member 2023-12-31 0000312257 ivfh:FinanceLease6Member 2021-07-12 0000312257 ivfh:FinanceLease6Member 2021-07-12 2021-07-12 0000312257 ivfh:FinanceLease6Member 2024-01-01 2024-03-31 0000312257 ivfh:FinanceLease5Member 2024-03-31 0000312257 ivfh:FinanceLease5Member 2023-12-31 0000312257 ivfh:FinanceLease5Member 2021-07-15 0000312257 ivfh:FinanceLease5Member 2021-07-15 2021-07-15 0000312257 ivfh:FinanceLease5Member 2024-01-01 2024-03-31 0000312257 ivfh:FinanceLease1Member 2024-03-31 0000312257 ivfh:FinanceLease1Member 2023-12-31 0000312257 ivfh:FinanceLease1Member 2020-10-14 2020-10-14 0000312257 ivfh:FinanceLease1Member 2020-10-14 0000312257 ivfh:FinanceLease1Member 2024-01-01 2024-03-31 0000312257 ivfh:FinanceLease2Member 2024-03-31 0000312257 ivfh:FinanceLease2Member 2023-12-31 0000312257 ivfh:FinanceLease2Member 2020-03-31 2020-03-31 0000312257 ivfh:FinanceLease2Member 2020-03-31 0000312257 ivfh:FinanceLease2Member 2024-01-01 2024-03-31 0000312257 ivfh:FinanceLease3Member 2024-03-31 0000312257 ivfh:FinanceLease3Member 2023-12-31 0000312257 ivfh:FinanceLease3Member 2018-11-05 2018-11-05 0000312257 ivfh:FinanceLease3Member 2018-11-05 0000312257 ivfh:FinanceLease3Member 2024-01-01 2024-03-31 0000312257 ivfh:FinanceLease4Member 2024-03-31 0000312257 ivfh:FinanceLease4Member 2023-12-31 0000312257 ivfh:FinanceLease4Member 2019-08-23 0000312257 ivfh:FinanceLease4Member 2024-01-01 2024-03-31 0000312257 ivfh:FinanceLease4Member 2019-08-23 2019-08-23 0000312257 ivfh:FinanceLease7Member 2024-03-31 0000312257 ivfh:FinanceLease7Member 2023-12-31 0000312257 ivfh:FinanceLease7Member 2022-02-04 0000312257 ivfh:FinanceLease7Member 2024-01-01 2024-03-31 0000312257 ivfh:FinanceLease7Member 2022-02-04 2022-02-04 0000312257 ivfh:ArtisanMember 2024-03-31 0000312257 us-gaap:TradeNamesMember 2024-03-31 0000312257 us-gaap:TradeNamesMember 2023-12-31 0000312257 2023-02-03 2023-02-03 0000312257 ivfh:FormerCEOAndDirectorMember 2023-02-03 0000312257 ivfh:FormerCEOAndDirectorMember 2023-02-03 2023-02-03 0000312257 ivfh:SharesToBeDeliveredOnJune12027Member ivfh:FormerCEOAndDirectorMember 2023-02-03 2023-02-03 0000312257 us-gaap:OtherInsuranceProductLineMember ivfh:FormerCEOAndDirectorMember 2023-02-03 2023-02-03 0000312257 ivfh:FormerCEOAndDirectorMember 2024-01-01 2024-03-31 0000312257 ivfh:DirectorOfStrategicAcquisitionsMember 2023-02-28 2023-02-28 0000312257 ivfh:PaymentDueUponExecutionOfAgreementMember ivfh:DirectorOfStrategicAcquisitionsMember 2023-02-28 2023-02-28 0000312257 ivfh:PaymentDueMarch152023Member ivfh:DirectorOfStrategicAcquisitionsMember 2023-02-28 2023-02-28 0000312257 ivfh:PaymentDueOnApril152023Member ivfh:DirectorOfStrategicAcquisitionsMember 2023-02-28 2023-02-28 0000312257 us-gaap:OtherInsuranceProductLineMember ivfh:DirectorOfStrategicAcquisitionsMember 2023-02-28 2023-02-28 0000312257 ivfh:DirectorOfStrategicAcquisitionsMember 2024-01-01 2024-03-31 0000312257 ivfh:RichardTangMember 2024-02-06 2024-02-06 0000312257 ivfh:LegalFeesMember ivfh:RichardTangMember 2024-02-06 2024-02-06 0000312257 ivfh:PaymentDueMarch42024Member ivfh:RichardTangMember 2024-02-06 2024-02-06 0000312257 ivfh:PaymentDueMarch112024Member ivfh:RichardTangMember 2024-03-11 2024-07-01 0000312257 ivfh:MrKlepfishMember 2024-01-01 2024-03-31 0000312257 us-gaap:OtherInsuranceProductLineMember ivfh:MrWiernaszMember 2024-01-01 2024-03-31 0000312257 ivfh:MrTangMember 2024-01-01 2024-03-31 0000312257 us-gaap:OtherInsuranceProductLineMember ivfh:MrTangMember 2024-01-01 2024-03-31 0000312257 ivfh:CashPaymentDueMarch62026Member ivfh:FormerCEOAndDirectorMember 2023-12-31 0000312257 ivfh:CashPaymentDueMarch62026Member ivfh:FormerCEOAndDirectorMember 2024-01-01 2024-03-31 0000312257 ivfh:CashPaymentDueMarch62026Member ivfh:FormerCEOAndDirectorMember 2024-03-31 0000312257 ivfh:PaymentDueUponExecutionOfAgreementMember ivfh:FormerCEOAndDirectorMember 2023-12-31 0000312257 ivfh:PaymentDueUponExecutionOfAgreementMember ivfh:FormerCEOAndDirectorMember 2024-01-01 2024-03-31 0000312257 ivfh:PaymentDueUponExecutionOfAgreementMember ivfh:FormerCEOAndDirectorMember 2024-03-31 0000312257 ivfh:SharesToBeDeliveredOnJune12027Member ivfh:FormerCEOAndDirectorMember 2023-12-31 0000312257 ivfh:SharesToBeDeliveredOnJune12027Member ivfh:FormerCEOAndDirectorMember 2024-01-01 2024-03-31 0000312257 ivfh:SharesToBeDeliveredOnJune12027Member ivfh:FormerCEOAndDirectorMember 2024-03-31 0000312257 ivfh:SharesIssuedApril2023Member ivfh:FormerCEOAndDirectorMember 2023-12-31 0000312257 ivfh:SharesIssuedApril2023Member ivfh:FormerCEOAndDirectorMember 2024-01-01 2024-03-31 0000312257 ivfh:SharesIssuedApril2023Member ivfh:FormerCEOAndDirectorMember 2024-03-31 0000312257 us-gaap:OtherInsuranceProductLineMember ivfh:FormerCEOAndDirectorMember 2023-12-31 0000312257 us-gaap:OtherInsuranceProductLineMember ivfh:FormerCEOAndDirectorMember 2024-01-01 2024-03-31 0000312257 us-gaap:OtherInsuranceProductLineMember ivfh:FormerCEOAndDirectorMember 2024-03-31 0000312257 ivfh:FormerCEOAndDirectorMember 2023-12-31 0000312257 ivfh:FormerCEOAndDirectorMember 2024-03-31 0000312257 ivfh:PaymentDueUponExecutionOfAgreementMember ivfh:DirectorOfStrategicAcquisitionsMember 2023-12-31 0000312257 ivfh:PaymentDueUponExecutionOfAgreementMember ivfh:DirectorOfStrategicAcquisitionsMember 2024-01-01 2024-03-31 0000312257 ivfh:PaymentDueUponExecutionOfAgreementMember ivfh:DirectorOfStrategicAcquisitionsMember 2024-03-31 0000312257 us-gaap:OtherInsuranceProductLineMember ivfh:DirectorOfStrategicAcquisitionsMember 2023-12-31 0000312257 us-gaap:OtherInsuranceProductLineMember ivfh:DirectorOfStrategicAcquisitionsMember 2024-01-01 2024-03-31 0000312257 us-gaap:OtherInsuranceProductLineMember ivfh:DirectorOfStrategicAcquisitionsMember 2024-03-31 0000312257 ivfh:DirectorOfStrategicAcquisitionsMember 2023-12-31 0000312257 ivfh:DirectorOfStrategicAcquisitionsMember 2024-03-31 0000312257 ivfh:PaymentDueUponExecutionOfAgreementMember srt:ChiefFinancialOfficerMember 2023-12-31 0000312257 ivfh:PaymentDueUponExecutionOfAgreementMember srt:ChiefFinancialOfficerMember 2024-01-01 2024-03-31 0000312257 ivfh:PaymentDueUponExecutionOfAgreementMember srt:ChiefFinancialOfficerMember 2024-03-31 0000312257 us-gaap:OtherInsuranceProductLineMember srt:ChiefFinancialOfficerMember 2023-12-31 0000312257 us-gaap:OtherInsuranceProductLineMember srt:ChiefFinancialOfficerMember 2024-01-01 2024-03-31 0000312257 us-gaap:OtherInsuranceProductLineMember srt:ChiefFinancialOfficerMember 2024-03-31 0000312257 srt:ChiefFinancialOfficerMember 2023-12-31 0000312257 srt:ChiefFinancialOfficerMember 2024-01-01 2024-03-31 0000312257 srt:ChiefFinancialOfficerMember 2024-03-31 0000312257 us-gaap:StockAppreciationRightsSARSMember 2023-05-15 2023-05-15 0000312257 us-gaap:StockAppreciationRightsSARSMember 2023-05-15 0000312257 us-gaap:StockAppreciationRightsSARSMember 2023-05-16 2023-12-31 0000312257 us-gaap:StockAppreciationRightsSARSMember 2023-12-31 0000312257 us-gaap:StockAppreciationRightsSARSMember 2024-01-01 2024-03-31 0000312257 us-gaap:StockAppreciationRightsSARSMember 2024-03-31 0000312257 ivfh:MapleMarkTermLoan3Member 2024-03-31 0000312257 ivfh:MapleMarkTermLoan3Member 2023-12-31 0000312257 ivfh:MapleMarkTermLoan3Member 2023-06-13 0000312257 ivfh:MapleMarkTermLoan3Member 2023-01-04 2048-06-13 0000312257 ivfh:MapleMarkTermLoan3Member 2023-06-13 2023-06-13 0000312257 ivfh:MapleMarkTermLoan3Member 2024-01-01 2024-03-31 0000312257 ivfh:MapleMarkTermLoan3Member ivfh:PrincipalMember 2024-01-01 2024-03-31 0000312257 ivfh:MapleMarkTermLoan2Member 2024-03-31 0000312257 ivfh:MapleMarkTermLoan2Member 2023-12-31 0000312257 ivfh:MapleMarkTermLoan2Member 2022-06-06 0000312257 ivfh:MapleMarkTermLoan2Member 2023-06-09 2023-06-09 0000312257 ivfh:MapleMarkTermLoan2Member 2023-01-01 2033-06-01 0000312257 ivfh:MapleMarkTermLoan2Member 2023-06-09 0000312257 ivfh:MapleMarkTermLoan2Member 2022-06-06 2022-06-06 0000312257 ivfh:MapleMarkTermLoan2Member 2022-12-31 0000312257 ivfh:MapleMarkTermLoan2Member 2024-01-01 2024-03-31 0000312257 us-gaap:ConvertibleDebtMember 2024-03-31 0000312257 us-gaap:ConvertibleDebtMember 2023-12-31 0000312257 us-gaap:ConvertibleDebtMember 2024-01-01 2024-03-31 0000312257 ivfh:MrBennettMember 2024-03-31 0000312257 ivfh:PreviousCFOMember 2023-02-28 2023-02-28 0000312257 2023-02-28 2023-02-28 0000312257 ivfh:PreviousCEOMember 2023-01-01 2023-03-31 0000312257 ivfh:OfficersAndDirectorsMember 2023-01-01 2023-03-31 0000312257 srt:MinimumMember us-gaap:RestrictedStockMember 2023-01-01 2023-03-31 0000312257 srt:MaximumMember us-gaap:RestrictedStockMember 2023-01-01 2023-03-31 0000312257 2023-11-07 2023-11-07 0000312257 srt:ChiefExecutiveOfficerMember 2023-11-07 2023-11-07 0000312257 ivfh:MrBennettMember 2024-03-19 0000312257 srt:ChiefOperatingOfficerMember 2023-05-15 2023-05-15 0000312257 srt:ChiefOperatingOfficerMember 2024-01-01 2024-03-31 0000312257 srt:ChiefFinancialOfficerMember 2024-01-01 2024-01-01 0000312257 ivfh:SARsPricedAt150Member 2023-05-15 2023-05-15 0000312257 ivfh:SARsPricedAt150Member 2023-05-15 0000312257 ivfh:SARsPricedAt200Member 2023-05-15 2023-05-15 0000312257 ivfh:SARsPricedAt200Member 2023-05-15 0000312257 us-gaap:EmployeeStockOptionMember 2024-03-31 0000312257 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-03-31 0000312257 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-03-31 0000312257 ivfh:StockPriceTarget060Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget080Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget100Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget120Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget140Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget160Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget180Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget200Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget087Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget116Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget145Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget174Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget203Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget232Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget261Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget290Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget123Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget163Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget204Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget245Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget286Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget327Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget368Member 2024-01-01 2024-03-31 0000312257 ivfh:StockPriceTarget408Member 2024-01-01 2024-03-31 0000312257 srt:MinimumMember 2023-01-01 2023-12-31 0000312257 srt:MaximumMember 2023-01-01 2023-12-31 0000312257 2023-01-01 2023-12-31 0000312257 srt:MinimumMember us-gaap:StockAppreciationRightsSARSMember 2023-01-01 2023-12-31 0000312257 srt:MaximumMember us-gaap:StockAppreciationRightsSARSMember 2023-01-01 2023-12-31 0000312257 us-gaap:StockAppreciationRightsSARSMember 2023-01-01 2023-12-31 0000312257 us-gaap:EmployeeStockOptionMember ivfh:OptionsAt041Member 2024-01-01 2024-03-31 0000312257 us-gaap:EmployeeStockOptionMember ivfh:OptionsAt041Member 2024-03-31 0000312257 us-gaap:EmployeeStockOptionMember ivfh:OptionsAt050Member 2024-01-01 2024-03-31 0000312257 us-gaap:EmployeeStockOptionMember ivfh:OptionsAt050Member 2024-03-31 0000312257 us-gaap:EmployeeStockOptionMember ivfh:OptionsAt060Member 2024-01-01 2024-03-31 0000312257 us-gaap:EmployeeStockOptionMember ivfh:OptionsAt060Member 2024-03-31 0000312257 us-gaap:EmployeeStockOptionMember ivfh:OptionsAt100Member 2024-01-01 2024-03-31 0000312257 us-gaap:EmployeeStockOptionMember ivfh:OptionsAt100Member 2024-03-31 0000312257 us-gaap:EmployeeStockOptionMember ivfh:OptionsAt125Member 2024-01-01 2024-03-31 0000312257 us-gaap:EmployeeStockOptionMember ivfh:OptionsAt125Member 2024-03-31 0000312257 us-gaap:EmployeeStockOptionMember ivfh:OptionsAt175Member 2024-01-01 2024-03-31 0000312257 us-gaap:EmployeeStockOptionMember ivfh:OptionsAt175Member 2024-03-31 0000312257 us-gaap:EmployeeStockOptionMember 2023-12-31 0000312257 ivfh:GateGourmetMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0000312257 ivfh:GateGourmetMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0000312257 us-gaap:PerformanceSharesMember us-gaap:SubsequentEventMember 2024-04-17 2024-04-17 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure